activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1651017	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL5257	Homo sapiens	Kd		
Not Active	1651017	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL5257	Homo sapiens	Kd		
Not Active	1651018	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL5257	Homo sapiens	Kd		
Not Active	1651019	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL5257	Homo sapiens	Kd		
Not Active	1651020	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Kd			CHEMBL5257	Homo sapiens	Kd		
Not Active	1651021	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL5257	Homo sapiens	Kd		
Not Active	1651022	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL5257	Homo sapiens	Kd		
Not Active	1651023	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL5257	Homo sapiens	Kd		
Not Active	1651024	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL5257	Homo sapiens	Kd		
Not Active	1651025	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL5257	Homo sapiens	Kd		
	1652061	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	6700.0	CHEMBL5257	Homo sapiens	Kd	uM	6.7
Not Active	1652062	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL5257	Homo sapiens	Kd		
Not Active	1652063	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL5257	Homo sapiens	Kd		
Not Active	1652064	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL5257	Homo sapiens	Kd		
Not Active	1652065	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL5257	Homo sapiens	Kd		
Not Active	1652066	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL5257	Homo sapiens	Kd		
Not Active	1652067	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL5257	Homo sapiens	Kd		
Not Active	1652068	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL5257	Homo sapiens	Kd		
Not Active	1652069	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL5257	Homo sapiens	Kd		
Not Active	1652070	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL5257	Homo sapiens	Kd		
Not Active	1652071	CHEMBL860657	Average Binding Constant for NEK9; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL5257	Homo sapiens	Kd		
	2470297	CHEMBL987217	Inhibition of NEK9 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5257	Homo sapiens	INH	%	10.0
Not Evaluated	2476584	CHEMBL993448	Binding affinity to human NEK9 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL5257	Homo sapiens	Activity		
Not Evaluated	2476787	CHEMBL993448	Binding affinity to human NEK9 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL5257	Homo sapiens	Activity		
Not Evaluated	2478626	CHEMBL993448	Binding affinity to human NEK9 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL5257	Homo sapiens	Activity		
Not Evaluated	2478829	CHEMBL993448	Binding affinity to human NEK9 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL5257	Homo sapiens	Activity		
Not Evaluated	2479684	CHEMBL993448	Binding affinity to human NEK9 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL5257	Homo sapiens	Activity		
Not Evaluated	2480683	CHEMBL993448	Binding affinity to human NEK9 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL5257	Homo sapiens	Activity		
	2511984	CHEMBL973485	Inhibition of NEK9 at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	17.0	CHEMBL5257	Homo sapiens	INH	%	17.0
Not Evaluated	2577305	CHEMBL993448	Binding affinity to human NEK9 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL5257	Homo sapiens	Activity		
Not Evaluated	2577508	CHEMBL993448	Binding affinity to human NEK9 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL5257	Homo sapiens	Activity		
Not Evaluated	2593510	CHEMBL993448	Binding affinity to human NEK9 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL5257	Homo sapiens	Activity		
Not Evaluated	2593713	CHEMBL993448	Binding affinity to human NEK9 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL5257	Homo sapiens	Activity		
Not Evaluated	2593979	CHEMBL993448	Binding affinity to human NEK9 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL5257	Homo sapiens	Activity		
Not Evaluated	2594922	CHEMBL993448	Binding affinity to human NEK9 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL5257	Homo sapiens	Activity		
Not Evaluated	2595125	CHEMBL993448	Binding affinity to human NEK9 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL5257	Homo sapiens	Activity		
Not Evaluated	2595191	CHEMBL993448	Binding affinity to human NEK9 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL5257	Homo sapiens	Activity		
Not Evaluated	2596322	CHEMBL993448	Binding affinity to human NEK9 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL5257	Homo sapiens	Activity		
Not Evaluated	2597591	CHEMBL993448	Binding affinity to human NEK9 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL5257	Homo sapiens	Activity		
Not Evaluated	2597794	CHEMBL993448	Binding affinity to human NEK9 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL5257	Homo sapiens	Activity		
	2902930	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902931	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902932	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902933	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902934	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902935	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902936	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	9100.0	CHEMBL5257	Homo sapiens	Kd	nM	9100.0
	2902937	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902938	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902939	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902940	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902941	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902942	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902943	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902944	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902945	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902946	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902947	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902948	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902949	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902950	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902951	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902952	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902953	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902954	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902955	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902956	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902957	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902958	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902959	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902960	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902961	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902962	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	3100.0	CHEMBL5257	Homo sapiens	Kd	nM	3100.0
	2902963	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902964	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902965	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902966	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2902967	CHEMBL1061081	Binding constant for NEK9 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	2921240	CHEMBL1048298	Inhibition of NEK9 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	89.0	CHEMBL5257	Homo sapiens	Activity	%	89.0
	3213987	CHEMBL1116735	Inhibition of NEK9 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	3.0	CHEMBL5257	Homo sapiens	INH	%	3.0
	3224900	CHEMBL1100978	Inhibition of NEK9 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	3226279	CHEMBL1100978	Inhibition of NEK9 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	3332057	CHEMBL1166595	Inhibition of NEK9 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	3333472	CHEMBL1166595	Inhibition of NEK9 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	3334877	CHEMBL1166595	Inhibition of NEK9 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	3336297	CHEMBL1166595	Inhibition of NEK9 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	3337596	CHEMBL1166595	Inhibition of NEK9 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	3338927	CHEMBL1166595	Inhibition of NEK9 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	3339181	CHEMBL1166595	Inhibition of NEK9 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	3340484	CHEMBL1166595	Inhibition of NEK9 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	3341839	CHEMBL1166595	Inhibition of NEK9 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	3343286	CHEMBL1166595	Inhibition of NEK9 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	3358705	CHEMBL1174947	Inhibition of NEK9 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	41.0	CHEMBL5257	Homo sapiens	INH	%	41.0
	3359147	CHEMBL1174947	Inhibition of NEK9 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	12.0	CHEMBL5257	Homo sapiens	INH	%	12.0
	3443466	CHEMBL1244232	Inhibition of NEK9 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	5.0	CHEMBL5257	Homo sapiens	INH	%	5.0
	3443683	CHEMBL1244232	Inhibition of NEK9 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	6.0	CHEMBL5257	Homo sapiens	INH	%	6.0
	3444838	CHEMBL1244232	Inhibition of NEK9 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	5.0	CHEMBL5257	Homo sapiens	INH	%	5.0
	3445462	CHEMBL1244232	Inhibition of NEK9 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	3.0	CHEMBL5257	Homo sapiens	INH	%	3.0
	3445679	CHEMBL1244232	Inhibition of NEK9 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	3.0	CHEMBL5257	Homo sapiens	INH	%	3.0
	3448533	CHEMBL1244541	Binding affinity to NEK9	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	3449763	CHEMBL1244541	Binding affinity to NEK9	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	3449943	CHEMBL1244541	Binding affinity to NEK9	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	3450166	CHEMBL1244541	Binding affinity to NEK9	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	3450372	CHEMBL1244541	Binding affinity to NEK9	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	3450822	CHEMBL1244541	Binding affinity to NEK9	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	3451081	CHEMBL1244541	Binding affinity to NEK9	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	uM	10.0
	3463300	CHEMBL1252602	Inhibition of NEK9 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	15.0	CHEMBL5257	Homo sapiens	INH	%	15.0
	3463844	CHEMBL1252602	Inhibition of NEK9 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	12.0	CHEMBL5257	Homo sapiens	INH	%	12.0
	3464063	CHEMBL1252602	Inhibition of NEK9 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	88.0	CHEMBL5257	Homo sapiens	INH	%	88.0
	6341002	CHEMBL1827627	Activity of NEK9 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	99.0	CHEMBL5257	Homo sapiens	Activity	%	99.0
	6385658	CHEMBL1838131	Inhibition of human NEK9 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	6385659	CHEMBL1838131	Inhibition of human NEK9 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	6385660	CHEMBL1838131	Inhibition of human NEK9 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	6385661	CHEMBL1838131	Inhibition of human NEK9 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	6385662	CHEMBL1838131	Inhibition of human NEK9 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	7567106	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7567565	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7568036	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7568504	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7568936	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7569079	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7569539	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7570011	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7570474	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7570901	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7571055	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7571512	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	790.0	CHEMBL5257	Homo sapiens	Kd	nM	790.0
	7571988	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7573036	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7573493	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7573969	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7573996	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7574404	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	800.0	CHEMBL5257	Homo sapiens	Kd	nM	800.0
	7575014	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7575475	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7575969	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7576377	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7576988	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7577447	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	470.0	CHEMBL5257	Homo sapiens	Kd	nM	470.0
	7577483	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7577953	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7578358	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	150.0	CHEMBL5257	Homo sapiens	Kd	nM	150.0
	7578996	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7579370	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7579852	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	520.0	CHEMBL5257	Homo sapiens	Kd	nM	520.0
	7580321	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7580724	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7581742	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7582213	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7582677	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7583077	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7583258	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7583655	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7584100	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7584571	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7585033	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	16.0	CHEMBL5257	Homo sapiens	Kd	nM	16.0
	7585437	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7585588	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7585996	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7586442	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7586913	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7587367	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7587549	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7587968	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7588421	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7588892	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7589514	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7589938	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	5400.0	CHEMBL5257	Homo sapiens	Kd	nM	5400.0
	7590405	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7590888	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7591487	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7591909	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	9100.0	CHEMBL5257	Homo sapiens	Kd	nM	9100.0
	7592381	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	=	Kd	nM	1100.0	CHEMBL5257	Homo sapiens	Kd	nM	1100.0
	7592412	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7592865	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7593454	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1800.0	CHEMBL5257	Homo sapiens	Kd	nM	1800.0
	7593889	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7594392	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7594844	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7595422	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7595898	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7596369	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7596816	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7597405	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7597878	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7598348	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5257	Homo sapiens	Kd	nM	10000.0
	7598790	CHEMBL1908401	Binding constant for NEK9 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	3100.0	CHEMBL5257	Homo sapiens	Kd	nM	3100.0
	8003600	CHEMBL1942755	Inhibition of human NEK9 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	8003601	CHEMBL1942755	Inhibition of human NEK9 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	8003602	CHEMBL1942755	Inhibition of human NEK9 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	8003603	CHEMBL1942755	Inhibition of human NEK9 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	8047144	CHEMBL1958973	Inhibition of NEK9 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	8061328	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	7.64	CHEMBL5257	Homo sapiens	Inhibition	%	7.64
	8061505	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-0.84	CHEMBL5257	Homo sapiens	Inhibition	%	-0.84
	8061836	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	10.14	CHEMBL5257	Homo sapiens	Inhibition	%	10.14
	8062027	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.88	CHEMBL5257	Homo sapiens	Inhibition	%	2.88
	8062367	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	12.24	CHEMBL5257	Homo sapiens	Inhibition	%	12.24
	8062529	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	13.68	CHEMBL5257	Homo sapiens	Inhibition	%	13.68
	8062753	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	5.79	CHEMBL5257	Homo sapiens	Inhibition	%	5.79
	8062851	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	5.33	CHEMBL5257	Homo sapiens	Inhibition	%	5.33
	8063207	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.05	CHEMBL5257	Homo sapiens	Inhibition	%	-0.05
	8063374	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	6.79	CHEMBL5257	Homo sapiens	Inhibition	%	6.79
	8063706	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	6.53	CHEMBL5257	Homo sapiens	Inhibition	%	6.53
	8063888	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	4.67	CHEMBL5257	Homo sapiens	Inhibition	%	4.67
	8064112	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.97	CHEMBL5257	Homo sapiens	Inhibition	%	3.97
	8064227	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	10.37	CHEMBL5257	Homo sapiens	Inhibition	%	10.37
	8064437	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.42	CHEMBL5257	Homo sapiens	Inhibition	%	0.42
	8064661	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	5.37	CHEMBL5257	Homo sapiens	Inhibition	%	5.37
	8064799	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-0.52	CHEMBL5257	Homo sapiens	Inhibition	%	-0.52
	8064965	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	6.74	CHEMBL5257	Homo sapiens	Inhibition	%	6.74
	8065189	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	4.0	CHEMBL5257	Homo sapiens	Inhibition	%	4.0
	8065305	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	6.43	CHEMBL5257	Homo sapiens	Inhibition	%	6.43
	8065704	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.67	CHEMBL5257	Homo sapiens	Inhibition	%	1.67
	8065819	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	7.55	CHEMBL5257	Homo sapiens	Inhibition	%	7.55
	8066253	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.19	CHEMBL5257	Homo sapiens	Inhibition	%	0.19
	8066389	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	9.31	CHEMBL5257	Homo sapiens	Inhibition	%	9.31
	8066779	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	3.42	CHEMBL5257	Homo sapiens	Inhibition	%	3.42
	8066903	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	7.82	CHEMBL5257	Homo sapiens	Inhibition	%	7.82
	8067127	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	15.38	CHEMBL5257	Homo sapiens	Inhibition	%	15.38
	8067302	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.21	CHEMBL5257	Homo sapiens	Inhibition	%	2.21
	8067423	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	5.29	CHEMBL5257	Homo sapiens	Inhibition	%	5.29
	8067647	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	5.49	CHEMBL5257	Homo sapiens	Inhibition	%	5.49
	8067857	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.52	CHEMBL5257	Homo sapiens	Inhibition	%	2.52
	8067992	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	17.31	CHEMBL5257	Homo sapiens	Inhibition	%	17.31
	8068216	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	69.86	CHEMBL5257	Homo sapiens	Inhibition	%	69.86
	8068380	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	8.32	CHEMBL5257	Homo sapiens	Inhibition	%	8.32
	8068729	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	3.12	CHEMBL5257	Homo sapiens	Inhibition	%	3.12
	8068903	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	7.16	CHEMBL5257	Homo sapiens	Inhibition	%	7.16
	8069252	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.86	CHEMBL5257	Homo sapiens	Inhibition	%	1.86
	8069547	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	11.68	CHEMBL5257	Homo sapiens	Inhibition	%	11.68
	8069708	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	4.83	CHEMBL5257	Homo sapiens	Inhibition	%	4.83
	8070058	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.67	CHEMBL5257	Homo sapiens	Inhibition	%	0.67
	8070230	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	7.56	CHEMBL5257	Homo sapiens	Inhibition	%	7.56
	8070579	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	3.68	CHEMBL5257	Homo sapiens	Inhibition	%	3.68
	8070877	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	45.37	CHEMBL5257	Homo sapiens	Inhibition	%	45.37
	8071034	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.08	CHEMBL5257	Homo sapiens	Inhibition	%	3.08
	8071258	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	10.95	CHEMBL5257	Homo sapiens	Inhibition	%	10.95
	8071384	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.6	CHEMBL5257	Homo sapiens	Inhibition	%	1.6
	8071557	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.29	CHEMBL5257	Homo sapiens	Inhibition	%	0.29
	8071781	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	1.02	CHEMBL5257	Homo sapiens	Inhibition	%	1.02
	8071906	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	2.93	CHEMBL5257	Homo sapiens	Inhibition	%	2.93
	8072220	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-4.74	CHEMBL5257	Homo sapiens	Inhibition	%	-4.74
	8072601	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	4.39	CHEMBL5257	Homo sapiens	Inhibition	%	4.39
	8072726	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	4.16	CHEMBL5257	Homo sapiens	Inhibition	%	4.16
	8073117	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.52	CHEMBL5257	Homo sapiens	Inhibition	%	3.52
	8073242	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-1.57	CHEMBL5257	Homo sapiens	Inhibition	%	-1.57
	8073466	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-3.04	CHEMBL5257	Homo sapiens	Inhibition	%	-3.04
	8073585	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	2.0	CHEMBL5257	Homo sapiens	Inhibition	%	2.0
	8073818	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.95	CHEMBL5257	Homo sapiens	Inhibition	%	0.95
	8074194	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	6.76	CHEMBL5257	Homo sapiens	Inhibition	%	6.76
	8074324	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.62	CHEMBL5257	Homo sapiens	Inhibition	%	0.62
	8074548	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	3.25	CHEMBL5257	Homo sapiens	Inhibition	%	3.25
	8074705	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	10.92	CHEMBL5257	Homo sapiens	Inhibition	%	10.92
	8075056	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	4.56	CHEMBL5257	Homo sapiens	Inhibition	%	4.56
	8075167	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	4.02	CHEMBL5257	Homo sapiens	Inhibition	%	4.02
	8075391	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.56	CHEMBL5257	Homo sapiens	Inhibition	%	0.56
	8075404	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.93	CHEMBL5257	Homo sapiens	Inhibition	%	-0.93
	8075628	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	3.04	CHEMBL5257	Homo sapiens	Inhibition	%	3.04
	8075769	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	-5.63	CHEMBL5257	Homo sapiens	Inhibition	%	-5.63
	8076135	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	35.87	CHEMBL5257	Homo sapiens	Inhibition	%	35.87
	8076283	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.22	CHEMBL5257	Homo sapiens	Inhibition	%	1.22
	8076641	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-1.45	CHEMBL5257	Homo sapiens	Inhibition	%	-1.45
	8076967	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	3.15	CHEMBL5257	Homo sapiens	Inhibition	%	3.15
	8077214	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	3.66	CHEMBL5257	Homo sapiens	Inhibition	%	3.66
	8077342	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.04	CHEMBL5257	Homo sapiens	Inhibition	%	2.04
	8077717	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	83.6	CHEMBL5257	Homo sapiens	Inhibition	%	83.6
	8077860	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.66	CHEMBL5257	Homo sapiens	Inhibition	%	1.66
	8078084	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	6.63	CHEMBL5257	Homo sapiens	Inhibition	%	6.63
	8078223	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	5.12	CHEMBL5257	Homo sapiens	Inhibition	%	5.12
	8078549	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	4.01	CHEMBL5257	Homo sapiens	Inhibition	%	4.01
	8078799	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-1.03	CHEMBL5257	Homo sapiens	Inhibition	%	-1.03
	8078915	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	5.36	CHEMBL5257	Homo sapiens	Inhibition	%	5.36
	8079139	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	6.96	CHEMBL5257	Homo sapiens	Inhibition	%	6.96
	8079297	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	62.4	CHEMBL5257	Homo sapiens	Inhibition	%	62.4
	8079663	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	5.9	CHEMBL5257	Homo sapiens	Inhibition	%	5.9
	8079802	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	2.31	CHEMBL5257	Homo sapiens	Inhibition	%	2.31
	8080131	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.01	CHEMBL5257	Homo sapiens	Inhibition	%	1.01
	8080383	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-3.08	CHEMBL5257	Homo sapiens	Inhibition	%	-3.08
	8080722	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	-0.31	CHEMBL5257	Homo sapiens	Inhibition	%	-0.31
	8080886	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	91.41	CHEMBL5257	Homo sapiens	Inhibition	%	91.41
	8081245	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	4.38	CHEMBL5257	Homo sapiens	Inhibition	%	4.38
	8081389	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	8.38	CHEMBL5257	Homo sapiens	Inhibition	%	8.38
	8081613	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	32.55	CHEMBL5257	Homo sapiens	Inhibition	%	32.55
	8081716	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.58	CHEMBL5257	Homo sapiens	Inhibition	%	1.58
	8081968	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	0.18	CHEMBL5257	Homo sapiens	Inhibition	%	0.18
	8082305	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	4.48	CHEMBL5257	Homo sapiens	Inhibition	%	4.48
	8082478	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.73	CHEMBL5257	Homo sapiens	Inhibition	%	0.73
	8082702	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.57	CHEMBL5257	Homo sapiens	Inhibition	%	3.57
	8082825	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	4.75	CHEMBL5257	Homo sapiens	Inhibition	%	4.75
	8083205	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	9.43	CHEMBL5257	Homo sapiens	Inhibition	%	9.43
	8083304	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	8.97	CHEMBL5257	Homo sapiens	Inhibition	%	8.97
	8083528	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.01	CHEMBL5257	Homo sapiens	Inhibition	%	2.01
	8083558	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-5.44	CHEMBL5257	Homo sapiens	Inhibition	%	-5.44
	8083782	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-2.86	CHEMBL5257	Homo sapiens	Inhibition	%	-2.86
	8083892	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	7.9	CHEMBL5257	Homo sapiens	Inhibition	%	7.9
	8084301	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	9.44	CHEMBL5257	Homo sapiens	Inhibition	%	9.44
	8084419	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	5.58	CHEMBL5257	Homo sapiens	Inhibition	%	5.58
	8084643	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	6.89	CHEMBL5257	Homo sapiens	Inhibition	%	6.89
	8084804	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	19.02	CHEMBL5257	Homo sapiens	Inhibition	%	19.02
	8085126	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	3.4	CHEMBL5257	Homo sapiens	Inhibition	%	3.4
	8085382	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	3.47	CHEMBL5257	Homo sapiens	Inhibition	%	3.47
	8085490	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	11.38	CHEMBL5257	Homo sapiens	Inhibition	%	11.38
	8085714	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	5.58	CHEMBL5257	Homo sapiens	Inhibition	%	5.58
	8085903	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	41.0	CHEMBL5257	Homo sapiens	Inhibition	%	41.0
	8086242	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	6.27	CHEMBL5257	Homo sapiens	Inhibition	%	6.27
	8086404	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	9.98	CHEMBL5257	Homo sapiens	Inhibition	%	9.98
	8086727	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.35	CHEMBL5257	Homo sapiens	Inhibition	%	0.35
	8086938	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	5.43	CHEMBL5257	Homo sapiens	Inhibition	%	5.43
	8087320	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	8.46	CHEMBL5257	Homo sapiens	Inhibition	%	8.46
	8087434	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	6.15	CHEMBL5257	Homo sapiens	Inhibition	%	6.15
	8087658	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	5.2	CHEMBL5257	Homo sapiens	Inhibition	%	5.2
	8087796	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.83	CHEMBL5257	Homo sapiens	Inhibition	%	5.83
	8088162	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.61	CHEMBL5257	Homo sapiens	Inhibition	%	5.61
	8088310	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	2.67	CHEMBL5257	Homo sapiens	Inhibition	%	2.67
	8088662	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	7.99	CHEMBL5257	Homo sapiens	Inhibition	%	7.99
	8088979	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.94	CHEMBL5257	Homo sapiens	Inhibition	%	0.94
	8089107	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.6	CHEMBL5257	Homo sapiens	Inhibition	%	-0.6
	8089479	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	4.67	CHEMBL5257	Homo sapiens	Inhibition	%	4.67
	8089599	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.56	CHEMBL5257	Homo sapiens	Inhibition	%	1.56
	8089823	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	4.12	CHEMBL5257	Homo sapiens	Inhibition	%	4.12
	8090003	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.92	CHEMBL5257	Homo sapiens	Inhibition	%	0.92
	8090168	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.4	CHEMBL5257	Homo sapiens	Inhibition	%	0.4
	8090392	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	6.33	CHEMBL5257	Homo sapiens	Inhibition	%	6.33
	8090559	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	7.69	CHEMBL5257	Homo sapiens	Inhibition	%	7.69
	8090698	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	4.9	CHEMBL5257	Homo sapiens	Inhibition	%	4.9
	8090922	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	2.65	CHEMBL5257	Homo sapiens	Inhibition	%	2.65
	8091127	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	5.77	CHEMBL5257	Homo sapiens	Inhibition	%	5.77
	8091264	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	5.75	CHEMBL5257	Homo sapiens	Inhibition	%	5.75
	8091488	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	7.78	CHEMBL5257	Homo sapiens	Inhibition	%	7.78
	8091643	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	10.2	CHEMBL5257	Homo sapiens	Inhibition	%	10.2
	8091983	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	5.41	CHEMBL5257	Homo sapiens	Inhibition	%	5.41
	8092120	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	2.53	CHEMBL5257	Homo sapiens	Inhibition	%	2.53
	8092495	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	9.93	CHEMBL5257	Homo sapiens	Inhibition	%	9.93
	8092643	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.82	CHEMBL5257	Homo sapiens	Inhibition	%	1.82
	8092867	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.95	CHEMBL5257	Homo sapiens	Inhibition	%	1.95
	8092996	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	38.35	CHEMBL5257	Homo sapiens	Inhibition	%	38.35
	8093308	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	7.44	CHEMBL5257	Homo sapiens	Inhibition	%	7.44
	8093448	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-2.13	CHEMBL5257	Homo sapiens	Inhibition	%	-2.13
	8093672	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-3.59	CHEMBL5257	Homo sapiens	Inhibition	%	-3.59
	8093811	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.52	CHEMBL5257	Homo sapiens	Inhibition	%	1.52
	8094155	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	6.89	CHEMBL5257	Homo sapiens	Inhibition	%	6.89
	8094335	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.25	CHEMBL5257	Homo sapiens	Inhibition	%	3.25
	8094734	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	4.13	CHEMBL5257	Homo sapiens	Inhibition	%	4.13
	8094890	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	8.77	CHEMBL5257	Homo sapiens	Inhibition	%	8.77
	8095254	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	17.05	CHEMBL5257	Homo sapiens	Inhibition	%	17.05
	8095457	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	15.52	CHEMBL5257	Homo sapiens	Inhibition	%	15.52
	8095822	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	7.97	CHEMBL5257	Homo sapiens	Inhibition	%	7.97
	8095970	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	6.67	CHEMBL5257	Homo sapiens	Inhibition	%	6.67
	8096311	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.88	CHEMBL5257	Homo sapiens	Inhibition	%	4.88
	8096450	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	5.18	CHEMBL5257	Homo sapiens	Inhibition	%	5.18
	8096674	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.79	CHEMBL5257	Homo sapiens	Inhibition	%	0.79
	8096830	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	8.5	CHEMBL5257	Homo sapiens	Inhibition	%	8.5
	8097201	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.21	CHEMBL5257	Homo sapiens	Inhibition	%	2.21
	8097288	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	83.67	CHEMBL5257	Homo sapiens	Inhibition	%	83.67
	8097508	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.58	CHEMBL5257	Homo sapiens	Inhibition	%	0.58
	8097882	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-5.29	CHEMBL5257	Homo sapiens	Inhibition	%	-5.29
	8098015	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	3.39	CHEMBL5257	Homo sapiens	Inhibition	%	3.39
	8098359	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.4	CHEMBL5257	Homo sapiens	Inhibition	%	0.4
	8098539	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.42	CHEMBL5257	Homo sapiens	Inhibition	%	1.42
	8098763	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.17	CHEMBL5257	Homo sapiens	Inhibition	%	1.17
	8098948	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	13.47	CHEMBL5257	Homo sapiens	Inhibition	%	13.47
	8099092	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	8.97	CHEMBL5257	Homo sapiens	Inhibition	%	8.97
	8099316	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	15.43	CHEMBL5257	Homo sapiens	Inhibition	%	15.43
	8099458	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	8.54	CHEMBL5257	Homo sapiens	Inhibition	%	8.54
	8099652	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	3.27	CHEMBL5257	Homo sapiens	Inhibition	%	3.27
	8100023	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	9.27	CHEMBL5257	Homo sapiens	Inhibition	%	9.27
	8100169	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	8.26	CHEMBL5257	Homo sapiens	Inhibition	%	8.26
	8100393	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	2.34	CHEMBL5257	Homo sapiens	Inhibition	%	2.34
	8100509	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.49	CHEMBL5257	Homo sapiens	Inhibition	%	4.49
	8100873	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	3.24	CHEMBL5257	Homo sapiens	Inhibition	%	3.24
	8101033	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.72	CHEMBL5257	Homo sapiens	Inhibition	%	4.72
	8101399	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	5.06	CHEMBL5257	Homo sapiens	Inhibition	%	5.06
	8101584	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	31.8	CHEMBL5257	Homo sapiens	Inhibition	%	31.8
	8101837	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	4.67	CHEMBL5257	Homo sapiens	Inhibition	%	4.67
	8102216	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-0.63	CHEMBL5257	Homo sapiens	Inhibition	%	-0.63
	8102347	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.76	CHEMBL5257	Homo sapiens	Inhibition	%	1.76
	8102571	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.38	CHEMBL5257	Homo sapiens	Inhibition	%	2.38
	8102691	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	8.39	CHEMBL5257	Homo sapiens	Inhibition	%	8.39
	8103093	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	5.01	CHEMBL5257	Homo sapiens	Inhibition	%	5.01
	8103289	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	6.95	CHEMBL5257	Homo sapiens	Inhibition	%	6.95
	8103651	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	8.72	CHEMBL5257	Homo sapiens	Inhibition	%	8.72
	8103801	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	5.55	CHEMBL5257	Homo sapiens	Inhibition	%	5.55
	8103986	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	4.02	CHEMBL5257	Homo sapiens	Inhibition	%	4.02
	8104210	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	5.35	CHEMBL5257	Homo sapiens	Inhibition	%	5.35
	8104358	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	9.51	CHEMBL5257	Homo sapiens	Inhibition	%	9.51
	8104728	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	7.27	CHEMBL5257	Homo sapiens	Inhibition	%	7.27
	8104842	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	9.06	CHEMBL5257	Homo sapiens	Inhibition	%	9.06
	8105066	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	9.35	CHEMBL5257	Homo sapiens	Inhibition	%	9.35
	8105206	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	3.96	CHEMBL5257	Homo sapiens	Inhibition	%	3.96
	8105372	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.67	CHEMBL5257	Homo sapiens	Inhibition	%	2.67
	8105596	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	62.01	CHEMBL5257	Homo sapiens	Inhibition	%	62.01
	8105734	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	8.49	CHEMBL5257	Homo sapiens	Inhibition	%	8.49
	8106014	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.96	CHEMBL5257	Homo sapiens	Inhibition	%	1.96
	8106179	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	5.28	CHEMBL5257	Homo sapiens	Inhibition	%	5.28
	8106403	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	5.9	CHEMBL5257	Homo sapiens	Inhibition	%	5.9
	8106559	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	7.1	CHEMBL5257	Homo sapiens	Inhibition	%	7.1
	8106912	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.83	CHEMBL5257	Homo sapiens	Inhibition	%	1.83
	8107033	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	3.07	CHEMBL5257	Homo sapiens	Inhibition	%	3.07
	8107257	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.16	CHEMBL5257	Homo sapiens	Inhibition	%	1.16
	8107429	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	8.36	CHEMBL5257	Homo sapiens	Inhibition	%	8.36
	8107630	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	3.62	CHEMBL5257	Homo sapiens	Inhibition	%	3.62
	8107989	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	10.98	CHEMBL5257	Homo sapiens	Inhibition	%	10.98
	8108147	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	7.04	CHEMBL5257	Homo sapiens	Inhibition	%	7.04
	8108546	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	2.84	CHEMBL5257	Homo sapiens	Inhibition	%	2.84
	8108693	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	77.39	CHEMBL5257	Homo sapiens	Inhibition	%	77.39
	8109059	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	5.0	CHEMBL5257	Homo sapiens	Inhibition	%	5.0
	8109397	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	5.19	CHEMBL5257	Homo sapiens	Inhibition	%	5.19
	8109527	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	3.47	CHEMBL5257	Homo sapiens	Inhibition	%	3.47
	8109922	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	97.21	CHEMBL5257	Homo sapiens	Inhibition	%	97.21
	8110054	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	10.44	CHEMBL5257	Homo sapiens	Inhibition	%	10.44
	8110333	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.42	CHEMBL5257	Homo sapiens	Inhibition	%	2.42
	8110723	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.61	CHEMBL5257	Homo sapiens	Inhibition	%	0.61
	8110881	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F	Outside typical range	CHEMBL1794064	=	Inhibition	%	-15.17	CHEMBL5257	Homo sapiens	Inhibition	%	-15.17
	8111228	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	3.74	CHEMBL5257	Homo sapiens	Inhibition	%	3.74
	8111579	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-1.1	CHEMBL5257	Homo sapiens	Inhibition	%	-1.1
	8111745	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	10.35	CHEMBL5257	Homo sapiens	Inhibition	%	10.35
	8111950	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	8.57	CHEMBL5257	Homo sapiens	Inhibition	%	8.57
	8112174	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.73	CHEMBL5257	Homo sapiens	Inhibition	%	4.73
	8112311	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	4.23	CHEMBL5257	Homo sapiens	Inhibition	%	4.23
	8112479	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	9.14	CHEMBL5257	Homo sapiens	Inhibition	%	9.14
	8112703	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	5.04	CHEMBL5257	Homo sapiens	Inhibition	%	5.04
	8112875	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.36	CHEMBL5257	Homo sapiens	Inhibition	%	-0.36
	8113027	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	89.71	CHEMBL5257	Homo sapiens	Inhibition	%	89.71
	8113251	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	7.21	CHEMBL5257	Homo sapiens	Inhibition	%	7.21
	8113387	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.79	CHEMBL5257	Homo sapiens	Inhibition	%	0.79
	8113735	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	5.85	CHEMBL5257	Homo sapiens	Inhibition	%	5.85
	8113851	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.96	CHEMBL5257	Homo sapiens	Inhibition	%	0.96
	8114075	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	2.86	CHEMBL5257	Homo sapiens	Inhibition	%	2.86
	8114251	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	4.02	CHEMBL5257	Homo sapiens	Inhibition	%	4.02
	8114383	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	7.35	CHEMBL5257	Homo sapiens	Inhibition	%	7.35
	8114607	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	10.29	CHEMBL5257	Homo sapiens	Inhibition	%	10.29
	8114659	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	-0.48	CHEMBL5257	Homo sapiens	Inhibition	%	-0.48
	8114883	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	-4.93	CHEMBL5257	Homo sapiens	Inhibition	%	-4.93
	8115049	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	5.05	CHEMBL5257	Homo sapiens	Inhibition	%	5.05
	8115214	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-9.04	CHEMBL5257	Homo sapiens	Inhibition	%	-9.04
	8115438	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.45	CHEMBL5257	Homo sapiens	Inhibition	%	0.45
	8115558	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	3.95	CHEMBL5257	Homo sapiens	Inhibition	%	3.95
	8115915	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.02	CHEMBL5257	Homo sapiens	Inhibition	%	0.02
	8116074	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	2.95	CHEMBL5257	Homo sapiens	Inhibition	%	2.95
	8116501	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.14	CHEMBL5257	Homo sapiens	Inhibition	%	2.14
	8116635	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	2.13	CHEMBL5257	Homo sapiens	Inhibition	%	2.13
	8117031	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	-0.67	CHEMBL5257	Homo sapiens	Inhibition	%	-0.67
	8117202	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.8	CHEMBL5257	Homo sapiens	Inhibition	%	1.8
	8117584	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	7.49	CHEMBL5257	Homo sapiens	Inhibition	%	7.49
	8117714	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-1.85	CHEMBL5257	Homo sapiens	Inhibition	%	-1.85
	8117938	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	4.02	CHEMBL5257	Homo sapiens	Inhibition	%	4.02
	8118076	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	6.39	CHEMBL5257	Homo sapiens	Inhibition	%	6.39
	8118416	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	4.85	CHEMBL5257	Homo sapiens	Inhibition	%	4.85
	8118588	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.96	CHEMBL5257	Homo sapiens	Inhibition	%	2.96
	8118948	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	8.43	CHEMBL5257	Homo sapiens	Inhibition	%	8.43
	8119219	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	7.92	CHEMBL5257	Homo sapiens	Inhibition	%	7.92
	8119378	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	4.68	CHEMBL5257	Homo sapiens	Inhibition	%	4.68
	8119769	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.5	CHEMBL5257	Homo sapiens	Inhibition	%	2.5
	8119888	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.58	CHEMBL5257	Homo sapiens	Inhibition	%	0.58
	8120112	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	-7.92	CHEMBL5257	Homo sapiens	Inhibition	%	-7.92
	8120251	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.38	CHEMBL5257	Homo sapiens	Inhibition	%	1.38
	8120411	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	8.02	CHEMBL5257	Homo sapiens	Inhibition	%	8.02
	8120635	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.71	CHEMBL5257	Homo sapiens	Inhibition	%	-1.71
	8120836	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	5.22	CHEMBL5257	Homo sapiens	Inhibition	%	5.22
	8120964	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	2.87	CHEMBL5257	Homo sapiens	Inhibition	%	2.87
	8121188	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	4.79	CHEMBL5257	Homo sapiens	Inhibition	%	4.79
	8121360	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	4.6	CHEMBL5257	Homo sapiens	Inhibition	%	4.6
	8121527	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	2.93	CHEMBL5257	Homo sapiens	Inhibition	%	2.93
	8121751	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-6.07	CHEMBL5257	Homo sapiens	Inhibition	%	-6.07
	8121914	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	8.49	CHEMBL5257	Homo sapiens	Inhibition	%	8.49
	8122259	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	5.01	CHEMBL5257	Homo sapiens	Inhibition	%	5.01
	8122397	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	6.01	CHEMBL5257	Homo sapiens	Inhibition	%	6.01
	8122741	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.67	CHEMBL5257	Homo sapiens	Inhibition	%	5.67
	8122908	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.92	CHEMBL5257	Homo sapiens	Inhibition	%	4.92
	8123132	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	8.15	CHEMBL5257	Homo sapiens	Inhibition	%	8.15
	8123274	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	16.7	CHEMBL5257	Homo sapiens	Inhibition	%	16.7
	8123552	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	2.11	CHEMBL5257	Homo sapiens	Inhibition	%	2.11
	8123702	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	3.36	CHEMBL5257	Homo sapiens	Inhibition	%	3.36
	8123926	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	1.08	CHEMBL5257	Homo sapiens	Inhibition	%	1.08
	8124093	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.98	CHEMBL5257	Homo sapiens	Inhibition	%	0.98
	8124436	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	10.7	CHEMBL5257	Homo sapiens	Inhibition	%	10.7
	8124575	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.95	CHEMBL5257	Homo sapiens	Inhibition	%	1.95
	8124964	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.45	CHEMBL5257	Homo sapiens	Inhibition	%	-0.45
	8125165	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	-0.95	CHEMBL5257	Homo sapiens	Inhibition	%	-0.95
	8125519	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	7.25	CHEMBL5257	Homo sapiens	Inhibition	%	7.25
	8125687	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	7.49	CHEMBL5257	Homo sapiens	Inhibition	%	7.49
	8126075	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	4.77	CHEMBL5257	Homo sapiens	Inhibition	%	4.77
	8126239	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	23.51	CHEMBL5257	Homo sapiens	Inhibition	%	23.51
	8126578	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	3.35	CHEMBL5257	Homo sapiens	Inhibition	%	3.35
	8126714	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	5.84	CHEMBL5257	Homo sapiens	Inhibition	%	5.84
	8126938	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	22.37	CHEMBL5257	Homo sapiens	Inhibition	%	22.37
	8127060	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.61	CHEMBL5257	Homo sapiens	Inhibition	%	4.61
	8127451	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	7.49	CHEMBL5257	Homo sapiens	Inhibition	%	7.49
	8127593	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	58.69	CHEMBL5257	Homo sapiens	Inhibition	%	58.69
	8127881	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	29.03	CHEMBL5257	Homo sapiens	Inhibition	%	29.03
	8128257	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	11.38	CHEMBL5257	Homo sapiens	Inhibition	%	11.38
	8128424	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	5.21	CHEMBL5257	Homo sapiens	Inhibition	%	5.21
	8128767	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	26.14	CHEMBL5257	Homo sapiens	Inhibition	%	26.14
	8128904	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.72	CHEMBL5257	Homo sapiens	Inhibition	%	3.72
	8129128	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	4.74	CHEMBL5257	Homo sapiens	Inhibition	%	4.74
	8129299	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.48	CHEMBL5257	Homo sapiens	Inhibition	%	-0.48
	8129488	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	-3.0	CHEMBL5257	Homo sapiens	Inhibition	%	-3.0
	8129851	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.12	CHEMBL5257	Homo sapiens	Inhibition	%	1.12
	8130012	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	4.65	CHEMBL5257	Homo sapiens	Inhibition	%	4.65
	8130236	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.64	CHEMBL5257	Homo sapiens	Inhibition	%	0.64
	8130408	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	3.91	CHEMBL5257	Homo sapiens	Inhibition	%	3.91
	8130568	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	6.44	CHEMBL5257	Homo sapiens	Inhibition	%	6.44
	8130908	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	8.18	CHEMBL5257	Homo sapiens	Inhibition	%	8.18
	8131271	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	9.33	CHEMBL5257	Homo sapiens	Inhibition	%	9.33
	8131391	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.8	CHEMBL5257	Homo sapiens	Inhibition	%	4.8
	8131615	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	5.94	CHEMBL5257	Homo sapiens	Inhibition	%	5.94
	8131782	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	16.13	CHEMBL5257	Homo sapiens	Inhibition	%	16.13
	8131923	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	5.7	CHEMBL5257	Homo sapiens	Inhibition	%	5.7
	8132147	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	17.86	CHEMBL5257	Homo sapiens	Inhibition	%	17.86
	8132209	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	81.38	CHEMBL5257	Homo sapiens	Inhibition	%	81.38
	8132433	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	5.24	CHEMBL5257	Homo sapiens	Inhibition	%	5.24
	8132580	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	4.45	CHEMBL5257	Homo sapiens	Inhibition	%	4.45
	8132748	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.21	CHEMBL5257	Homo sapiens	Inhibition	%	1.21
	8132972	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	3.22	CHEMBL5257	Homo sapiens	Inhibition	%	3.22
	8133093	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-0.09	CHEMBL5257	Homo sapiens	Inhibition	%	-0.09
	8133455	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.14	CHEMBL5257	Homo sapiens	Inhibition	%	0.14
	8133627	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.58	CHEMBL5257	Homo sapiens	Inhibition	%	-0.58
	8133807	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	6.54	CHEMBL5257	Homo sapiens	Inhibition	%	6.54
	8134031	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	30.06	CHEMBL5257	Homo sapiens	Inhibition	%	30.06
	8134179	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	4.69	CHEMBL5257	Homo sapiens	Inhibition	%	4.69
	8134563	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	5.95	CHEMBL5257	Homo sapiens	Inhibition	%	5.95
	8134747	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.57	CHEMBL5257	Homo sapiens	Inhibition	%	-0.57
	8134907	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	13.69	CHEMBL5257	Homo sapiens	Inhibition	%	13.69
	8135131	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.24	CHEMBL5257	Homo sapiens	Inhibition	%	5.24
	8135246	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	7.01	CHEMBL5257	Homo sapiens	Inhibition	%	7.01
	8135611	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	6.21	CHEMBL5257	Homo sapiens	Inhibition	%	6.21
	8135956	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	4.98	CHEMBL5257	Homo sapiens	Inhibition	%	4.98
	8136124	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	7.75	CHEMBL5257	Homo sapiens	Inhibition	%	7.75
	8136492	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	7.85	CHEMBL5257	Homo sapiens	Inhibition	%	7.85
	8136782	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	3.64	CHEMBL5257	Homo sapiens	Inhibition	%	3.64
	8136917	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	7.85	CHEMBL5257	Homo sapiens	Inhibition	%	7.85
	8137304	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.01	CHEMBL5257	Homo sapiens	Inhibition	%	1.01
	8137424	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-2.99	CHEMBL5257	Homo sapiens	Inhibition	%	-2.99
	8137648	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.53	CHEMBL5257	Homo sapiens	Inhibition	%	-0.53
	8137796	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-3.93	CHEMBL5257	Homo sapiens	Inhibition	%	-3.93
	8137962	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.9	CHEMBL5257	Homo sapiens	Inhibition	%	-2.9
	8138186	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.33	CHEMBL5257	Homo sapiens	Inhibition	%	1.33
	8138365	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	3.06	CHEMBL5257	Homo sapiens	Inhibition	%	3.06
	8138513	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	2.28	CHEMBL5257	Homo sapiens	Inhibition	%	2.28
	8138737	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	3.16	CHEMBL5257	Homo sapiens	Inhibition	%	3.16
	8138895	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	4.64	CHEMBL5257	Homo sapiens	Inhibition	%	4.64
	8139080	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	9.7	CHEMBL5257	Homo sapiens	Inhibition	%	9.7
	8139463	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.99	CHEMBL5257	Homo sapiens	Inhibition	%	5.99
	8139577	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	7.54	CHEMBL5257	Homo sapiens	Inhibition	%	7.54
	8139801	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	7.1	CHEMBL5257	Homo sapiens	Inhibition	%	7.1
	8139942	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	12.22	CHEMBL5257	Homo sapiens	Inhibition	%	12.22
	8140289	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.53	CHEMBL5257	Homo sapiens	Inhibition	%	2.53
	8140448	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	11.22	CHEMBL5257	Homo sapiens	Inhibition	%	11.22
	8140815	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	7.95	CHEMBL5257	Homo sapiens	Inhibition	%	7.95
	8141117	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	4.32	CHEMBL5257	Homo sapiens	Inhibition	%	4.32
	8141247	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.13	CHEMBL5257	Homo sapiens	Inhibition	%	3.13
	8141471	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	6.28	CHEMBL5257	Homo sapiens	Inhibition	%	6.28
	8141631	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	0.45	CHEMBL5257	Homo sapiens	Inhibition	%	0.45
	8141974	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	2.51	CHEMBL5257	Homo sapiens	Inhibition	%	2.51
	8142135	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	6.4	CHEMBL5257	Homo sapiens	Inhibition	%	6.4
	8142527	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	88.27	CHEMBL5257	Homo sapiens	Inhibition	%	88.27
	8142703	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-0.39	CHEMBL5257	Homo sapiens	Inhibition	%	-0.39
	8143076	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	4.93	CHEMBL5257	Homo sapiens	Inhibition	%	4.93
	8143231	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.62	CHEMBL5257	Homo sapiens	Inhibition	%	3.62
	8143418	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	9.81	CHEMBL5257	Homo sapiens	Inhibition	%	9.81
	8143642	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	7.24	CHEMBL5257	Homo sapiens	Inhibition	%	7.24
	8143801	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	8.93	CHEMBL5257	Homo sapiens	Inhibition	%	8.93
	8144139	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	6.05	CHEMBL5257	Homo sapiens	Inhibition	%	6.05
	8144278	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	11.57	CHEMBL5257	Homo sapiens	Inhibition	%	11.57
	8144502	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	7.57	CHEMBL5257	Homo sapiens	Inhibition	%	7.57
	8144632	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	5.05	CHEMBL5257	Homo sapiens	Inhibition	%	5.05
	8144785	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	5.37	CHEMBL5257	Homo sapiens	Inhibition	%	5.37
	8145009	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	7.69	CHEMBL5257	Homo sapiens	Inhibition	%	7.69
	8145146	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.93	CHEMBL5257	Homo sapiens	Inhibition	%	4.93
	8145459	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.78	CHEMBL5257	Homo sapiens	Inhibition	%	0.78
	8145807	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.33	CHEMBL5257	Homo sapiens	Inhibition	%	-0.33
	8145968	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	-4.22	CHEMBL5257	Homo sapiens	Inhibition	%	-4.22
	8146312	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-1.77	CHEMBL5257	Homo sapiens	Inhibition	%	-1.77
	8146472	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	8.39	CHEMBL5257	Homo sapiens	Inhibition	%	8.39
	8146863	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	102.37	CHEMBL5257	Homo sapiens	Inhibition	%	102.37
	8147032	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	4.62	CHEMBL5257	Homo sapiens	Inhibition	%	4.62
	8147398	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	8.12	CHEMBL5257	Homo sapiens	Inhibition	%	8.12
	8147551	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	6.07	CHEMBL5257	Homo sapiens	Inhibition	%	6.07
	8147962	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	6.38	CHEMBL5257	Homo sapiens	Inhibition	%	6.38
	8148120	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	7.33	CHEMBL5257	Homo sapiens	Inhibition	%	7.33
	8148458	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	5.79	CHEMBL5257	Homo sapiens	Inhibition	%	5.79
	8148821	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	12.59	CHEMBL5257	Homo sapiens	Inhibition	%	12.59
	8148959	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	6.05	CHEMBL5257	Homo sapiens	Inhibition	%	6.05
	8149342	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	2.5	CHEMBL5257	Homo sapiens	Inhibition	%	2.5
	8149476	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.64	CHEMBL5257	Homo sapiens	Inhibition	%	4.64
	8149700	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	7.8	CHEMBL5257	Homo sapiens	Inhibition	%	7.8
	8149798	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	6.95	CHEMBL5257	Homo sapiens	Inhibition	%	6.95
	8150147	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-0.1	CHEMBL5257	Homo sapiens	Inhibition	%	-0.1
	8150307	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	-6.03	CHEMBL5257	Homo sapiens	Inhibition	%	-6.03
	8150531	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.64	CHEMBL5257	Homo sapiens	Inhibition	%	0.64
	8150651	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.45	CHEMBL5257	Homo sapiens	Inhibition	%	-0.45
	8150816	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.89	CHEMBL5257	Homo sapiens	Inhibition	%	1.89
	8151040	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-3.87	CHEMBL5257	Homo sapiens	Inhibition	%	-3.87
	8151203	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.32	CHEMBL5257	Homo sapiens	Inhibition	%	0.32
	8151380	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	6.47	CHEMBL5257	Homo sapiens	Inhibition	%	6.47
	8151604	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.26	CHEMBL5257	Homo sapiens	Inhibition	%	2.26
	8151742	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	8.66	CHEMBL5257	Homo sapiens	Inhibition	%	8.66
	8151896	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	6.48	CHEMBL5257	Homo sapiens	Inhibition	%	6.48
	8152120	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	3.9	CHEMBL5257	Homo sapiens	Inhibition	%	3.9
	8152308	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	11.26	CHEMBL5257	Homo sapiens	Inhibition	%	11.26
	8152466	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	12.22	CHEMBL5257	Homo sapiens	Inhibition	%	12.22
	8152690	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	10.2	CHEMBL5257	Homo sapiens	Inhibition	%	10.2
	8152804	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	3.29	CHEMBL5257	Homo sapiens	Inhibition	%	3.29
	8153167	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-2.04	CHEMBL5257	Homo sapiens	Inhibition	%	-2.04
	8153304	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.67	CHEMBL5257	Homo sapiens	Inhibition	%	4.67
	8153528	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	6.0	CHEMBL5257	Homo sapiens	Inhibition	%	6.0
	8153685	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	3.24	CHEMBL5257	Homo sapiens	Inhibition	%	3.24
	8154042	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	11.9	CHEMBL5257	Homo sapiens	Inhibition	%	11.9
	8154139	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	4.01	CHEMBL5257	Homo sapiens	Inhibition	%	4.01
	8154363	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.97	CHEMBL5257	Homo sapiens	Inhibition	%	0.97
	8154489	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	6.87	CHEMBL5257	Homo sapiens	Inhibition	%	6.87
	8154872	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	4.28	CHEMBL5257	Homo sapiens	Inhibition	%	4.28
	8154992	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	5.75	CHEMBL5257	Homo sapiens	Inhibition	%	5.75
	8155392	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.57	CHEMBL5257	Homo sapiens	Inhibition	%	0.57
	8155553	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.78	CHEMBL5257	Homo sapiens	Inhibition	%	-2.78
	8155955	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	9.21	CHEMBL5257	Homo sapiens	Inhibition	%	9.21
	8156093	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	7.49	CHEMBL5257	Homo sapiens	Inhibition	%	7.49
	8156305	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.53	CHEMBL5257	Homo sapiens	Inhibition	%	1.53
	8156529	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.07	CHEMBL5257	Homo sapiens	Inhibition	%	3.07
	8156679	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.45	CHEMBL5257	Homo sapiens	Inhibition	%	3.45
	8157046	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	5.13	CHEMBL5257	Homo sapiens	Inhibition	%	5.13
	8157166	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.92	CHEMBL5257	Homo sapiens	Inhibition	%	1.92
	8157390	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	-5.55	CHEMBL5257	Homo sapiens	Inhibition	%	-5.55
	8157531	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	54.89	CHEMBL5257	Homo sapiens	Inhibition	%	54.89
	8157885	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	9.22	CHEMBL5257	Homo sapiens	Inhibition	%	9.22
	8158046	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-4.1	CHEMBL5257	Homo sapiens	Inhibition	%	-4.1
	8158296	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	18.22	CHEMBL5257	Homo sapiens	Inhibition	%	18.22
	8158678	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	6.52	CHEMBL5257	Homo sapiens	Inhibition	%	6.52
	8158847	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	11.58	CHEMBL5257	Homo sapiens	Inhibition	%	11.58
	8159206	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.79	CHEMBL5257	Homo sapiens	Inhibition	%	5.79
	8159550	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	5.56	CHEMBL5257	Homo sapiens	Inhibition	%	5.56
	8159681	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.91	CHEMBL5257	Homo sapiens	Inhibition	%	2.91
	8160046	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.13	CHEMBL5257	Homo sapiens	Inhibition	%	0.13
	8160183	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	6.26	CHEMBL5257	Homo sapiens	Inhibition	%	6.26
	8160557	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	2.41	CHEMBL5257	Homo sapiens	Inhibition	%	2.41
	8160851	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	4.87	CHEMBL5257	Homo sapiens	Inhibition	%	4.87
	8161001	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	5.2	CHEMBL5257	Homo sapiens	Inhibition	%	5.2
	8161368	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	16.18	CHEMBL5257	Homo sapiens	Inhibition	%	16.18
	8161717	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.76	CHEMBL5257	Homo sapiens	Inhibition	%	2.76
	8161855	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	86.13	CHEMBL5257	Homo sapiens	Inhibition	%	86.13
	8162209	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	9.03	CHEMBL5257	Homo sapiens	Inhibition	%	9.03
	8162369	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	2.54	CHEMBL5257	Homo sapiens	Inhibition	%	2.54
	8162593	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-1.83	CHEMBL5257	Homo sapiens	Inhibition	%	-1.83
	8162622	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	11.82	CHEMBL5257	Homo sapiens	Inhibition	%	11.82
	8162846	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	19.15	CHEMBL5257	Homo sapiens	Inhibition	%	19.15
	8162994	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	9.07	CHEMBL5257	Homo sapiens	Inhibition	%	9.07
	8163163	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	10.91	CHEMBL5257	Homo sapiens	Inhibition	%	10.91
	8163387	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	5.96	CHEMBL5257	Homo sapiens	Inhibition	%	5.96
	8163521	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	13.48	CHEMBL5257	Homo sapiens	Inhibition	%	13.48
	8163868	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	4.81	CHEMBL5257	Homo sapiens	Inhibition	%	4.81
	8164002	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	9.57	CHEMBL5257	Homo sapiens	Inhibition	%	9.57
	8164226	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	12.78	CHEMBL5257	Homo sapiens	Inhibition	%	12.78
	8164366	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	5.35	CHEMBL5257	Homo sapiens	Inhibition	%	5.35
	8164521	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.68	CHEMBL5257	Homo sapiens	Inhibition	%	1.68
	8164745	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	7.0	CHEMBL5257	Homo sapiens	Inhibition	%	7.0
	8164889	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-1.68	CHEMBL5257	Homo sapiens	Inhibition	%	-1.68
	8165183	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	5.86	CHEMBL5257	Homo sapiens	Inhibition	%	5.86
	8165324	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	4.91	CHEMBL5257	Homo sapiens	Inhibition	%	4.91
	8165548	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.96	CHEMBL5257	Homo sapiens	Inhibition	%	0.96
	8165691	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	49.9	CHEMBL5257	Homo sapiens	Inhibition	%	49.9
	8166041	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	-5.12	CHEMBL5257	Homo sapiens	Inhibition	%	-5.12
	8166179	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	10.59	CHEMBL5257	Homo sapiens	Inhibition	%	10.59
	8166403	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	9.48	CHEMBL5257	Homo sapiens	Inhibition	%	9.48
	8166533	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	9.92	CHEMBL5257	Homo sapiens	Inhibition	%	9.92
	8166858	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	5.56	CHEMBL5257	Homo sapiens	Inhibition	%	5.56
	8167170	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	7.58	CHEMBL5257	Homo sapiens	Inhibition	%	7.58
	8167311	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	31.97	CHEMBL5257	Homo sapiens	Inhibition	%	31.97
	8167699	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	4.88	CHEMBL5257	Homo sapiens	Inhibition	%	4.88
	8167832	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.14	CHEMBL5257	Homo sapiens	Inhibition	%	5.14
	8168056	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	6.41	CHEMBL5257	Homo sapiens	Inhibition	%	6.41
	8168180	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.85	CHEMBL5257	Homo sapiens	Inhibition	%	2.85
	8168545	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	5.71	CHEMBL5257	Homo sapiens	Inhibition	%	5.71
	8168681	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	2.47	CHEMBL5257	Homo sapiens	Inhibition	%	2.47
	8169069	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	15.55	CHEMBL5257	Homo sapiens	Inhibition	%	15.55
	8169211	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.89	CHEMBL5257	Homo sapiens	Inhibition	%	2.89
	8169515	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	8.8	CHEMBL5257	Homo sapiens	Inhibition	%	8.8
	8169873	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	7.1	CHEMBL5257	Homo sapiens	Inhibition	%	7.1
	8170018	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	5.43	CHEMBL5257	Homo sapiens	Inhibition	%	5.43
	8170242	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	-1.98	CHEMBL5257	Homo sapiens	Inhibition	%	-1.98
	8170367	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	4.06	CHEMBL5257	Homo sapiens	Inhibition	%	4.06
	8170731	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	5.3	CHEMBL5257	Homo sapiens	Inhibition	%	5.3
	8170866	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	6.73	CHEMBL5257	Homo sapiens	Inhibition	%	6.73
	8171287	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	0.16	CHEMBL5257	Homo sapiens	Inhibition	%	0.16
	8171504	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	16.98	CHEMBL5257	Homo sapiens	Inhibition	%	16.98
	8171645	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	4.77	CHEMBL5257	Homo sapiens	Inhibition	%	4.77
	8171869	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	9.86	CHEMBL5257	Homo sapiens	Inhibition	%	9.86
	8172022	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	3.6	CHEMBL5257	Homo sapiens	Inhibition	%	3.6
	8172378	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	9.7	CHEMBL5257	Homo sapiens	Inhibition	%	9.7
	8172506	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.09	CHEMBL5257	Homo sapiens	Inhibition	%	3.09
	8172872	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	5.15	CHEMBL5257	Homo sapiens	Inhibition	%	5.15
	8173008	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	4.44	CHEMBL5257	Homo sapiens	Inhibition	%	4.44
	8173232	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	2.04	CHEMBL5257	Homo sapiens	Inhibition	%	2.04
	8173397	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	7.16	CHEMBL5257	Homo sapiens	Inhibition	%	7.16
	8173538	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	-0.22	CHEMBL5257	Homo sapiens	Inhibition	%	-0.22
	8173762	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	6.61	CHEMBL5257	Homo sapiens	Inhibition	%	6.61
	8173849	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	10.21	CHEMBL5257	Homo sapiens	Inhibition	%	10.21
	8174073	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	10.4	CHEMBL5257	Homo sapiens	Inhibition	%	10.4
	8174205	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.09	CHEMBL5257	Homo sapiens	Inhibition	%	2.09
	8174577	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	9.43	CHEMBL5257	Homo sapiens	Inhibition	%	9.43
	8174699	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.99	CHEMBL5257	Homo sapiens	Inhibition	%	3.99
	8175066	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	8.54	CHEMBL5257	Homo sapiens	Inhibition	%	8.54
	8175202	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	11.34	CHEMBL5257	Homo sapiens	Inhibition	%	11.34
	8175426	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	11.04	CHEMBL5257	Homo sapiens	Inhibition	%	11.04
	8175682	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	12.4	CHEMBL5257	Homo sapiens	Inhibition	%	12.4
	8175845	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	8.48	CHEMBL5257	Homo sapiens	Inhibition	%	8.48
	8176222	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	2.32	CHEMBL5257	Homo sapiens	Inhibition	%	2.32
	8176371	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	3.11	CHEMBL5257	Homo sapiens	Inhibition	%	3.11
	8176727	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	15.57	CHEMBL5257	Homo sapiens	Inhibition	%	15.57
	8176857	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	2.13	CHEMBL5257	Homo sapiens	Inhibition	%	2.13
	8177081	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	2.33	CHEMBL5257	Homo sapiens	Inhibition	%	2.33
	8177223	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	4.65	CHEMBL5257	Homo sapiens	Inhibition	%	4.65
	8177585	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	2.96	CHEMBL5257	Homo sapiens	Inhibition	%	2.96
	8177749	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	6.71	CHEMBL5257	Homo sapiens	Inhibition	%	6.71
	8178113	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	0.27	CHEMBL5257	Homo sapiens	Inhibition	%	0.27
	8178425	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	7.4	CHEMBL5257	Homo sapiens	Inhibition	%	7.4
	8178552	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	3.89	CHEMBL5257	Homo sapiens	Inhibition	%	3.89
	8178925	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-2.12	CHEMBL5257	Homo sapiens	Inhibition	%	-2.12
	8179048	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	12.0	CHEMBL5257	Homo sapiens	Inhibition	%	12.0
	8179272	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	4.6	CHEMBL5257	Homo sapiens	Inhibition	%	4.6
	8179416	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	9.13	CHEMBL5257	Homo sapiens	Inhibition	%	9.13
	8179777	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	6.94	CHEMBL5257	Homo sapiens	Inhibition	%	6.94
	8180034	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	12.69	CHEMBL5257	Homo sapiens	Inhibition	%	12.69
	8180188	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	13.06	CHEMBL5257	Homo sapiens	Inhibition	%	13.06
	8180568	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	6.1	CHEMBL5257	Homo sapiens	Inhibition	%	6.1
	8180716	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	-1.19	CHEMBL5257	Homo sapiens	Inhibition	%	-1.19
	8180940	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	4.93	CHEMBL5257	Homo sapiens	Inhibition	%	4.93
	8181073	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	4.3	CHEMBL5257	Homo sapiens	Inhibition	%	4.3
	8181428	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	2.83	CHEMBL5257	Homo sapiens	Inhibition	%	2.83
	8181568	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	8.64	CHEMBL5257	Homo sapiens	Inhibition	%	8.64
	8181931	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	2.1	CHEMBL5257	Homo sapiens	Inhibition	%	2.1
	8182094	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	11.49	CHEMBL5257	Homo sapiens	Inhibition	%	11.49
	8182318	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	11.07	CHEMBL5257	Homo sapiens	Inhibition	%	11.07
	8182458	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.79	CHEMBL5257	Homo sapiens	Inhibition	%	4.79
	8182774	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	-1.84	CHEMBL5257	Homo sapiens	Inhibition	%	-1.84
	8182896	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.55	CHEMBL5257	Homo sapiens	Inhibition	%	1.55
	8183120	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	6.76	CHEMBL5257	Homo sapiens	Inhibition	%	6.76
	8183269	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	4.19	CHEMBL5257	Homo sapiens	Inhibition	%	4.19
	8183622	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-5.79	CHEMBL5257	Homo sapiens	Inhibition	%	-5.79
	8183764	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	9.05	CHEMBL5257	Homo sapiens	Inhibition	%	9.05
	8184124	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	4.13	CHEMBL5257	Homo sapiens	Inhibition	%	4.13
	8184390	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	19.2	CHEMBL5257	Homo sapiens	Inhibition	%	19.2
	8184537	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.71	CHEMBL5257	Homo sapiens	Inhibition	%	1.71
	8184761	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	9.08	CHEMBL5257	Homo sapiens	Inhibition	%	9.08
	8184918	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	6.56	CHEMBL5257	Homo sapiens	Inhibition	%	6.56
	8185291	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.38	CHEMBL5257	Homo sapiens	Inhibition	%	0.38
	8185422	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	7.62	CHEMBL5257	Homo sapiens	Inhibition	%	7.62
	8185777	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	1.67	CHEMBL5257	Homo sapiens	Inhibition	%	1.67
	8185916	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.27	CHEMBL5257	Homo sapiens	Inhibition	%	4.27
	8186140	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	5.87	CHEMBL5257	Homo sapiens	Inhibition	%	5.87
	8186281	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.45	CHEMBL5257	Homo sapiens	Inhibition	%	7.45
	8186669	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	11.29	CHEMBL5257	Homo sapiens	Inhibition	%	11.29
	8186808	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.67	CHEMBL5257	Homo sapiens	Inhibition	%	1.67
	8187130	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	5.2	CHEMBL5257	Homo sapiens	Inhibition	%	5.2
	8187478	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.79	CHEMBL5257	Homo sapiens	Inhibition	%	5.79
	8187626	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	4.07	CHEMBL5257	Homo sapiens	Inhibition	%	4.07
	8187979	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-0.89	CHEMBL5257	Homo sapiens	Inhibition	%	-0.89
	8188122	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	7.35	CHEMBL5257	Homo sapiens	Inhibition	%	7.35
	8188346	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	9.42	CHEMBL5257	Homo sapiens	Inhibition	%	9.42
	8188481	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	4.38	CHEMBL5257	Homo sapiens	Inhibition	%	4.38
	8188755	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.24	CHEMBL5257	Homo sapiens	Inhibition	%	6.24
	8189127	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	-0.27	CHEMBL5257	Homo sapiens	Inhibition	%	-0.27
	8189283	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	11.96	CHEMBL5257	Homo sapiens	Inhibition	%	11.96
	8189656	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-3.77	CHEMBL5257	Homo sapiens	Inhibition	%	-3.77
	8189788	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	8.12	CHEMBL5257	Homo sapiens	Inhibition	%	8.12
	8190012	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	10.22	CHEMBL5257	Homo sapiens	Inhibition	%	10.22
	8190144	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	3.73	CHEMBL5257	Homo sapiens	Inhibition	%	3.73
	8190508	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	9.48	CHEMBL5257	Homo sapiens	Inhibition	%	9.48
	8190645	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.17	CHEMBL5257	Homo sapiens	Inhibition	%	7.17
	8190869	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	5.09	CHEMBL5257	Homo sapiens	Inhibition	%	5.09
	8191033	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	7.64	CHEMBL5257	Homo sapiens	Inhibition	%	7.64
	8191171	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	0.16	CHEMBL5257	Homo sapiens	Inhibition	%	0.16
	8191395	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.76	CHEMBL5257	Homo sapiens	Inhibition	%	4.76
	8191491	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.49	CHEMBL5257	Homo sapiens	Inhibition	%	0.49
	8191837	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	10.17	CHEMBL5257	Homo sapiens	Inhibition	%	10.17
	8191986	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	8.92	CHEMBL5257	Homo sapiens	Inhibition	%	8.92
	8192210	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	-1.94	CHEMBL5257	Homo sapiens	Inhibition	%	-1.94
	8192339	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	1.2	CHEMBL5257	Homo sapiens	Inhibition	%	1.2
	8192707	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.46	CHEMBL5257	Homo sapiens	Inhibition	%	3.46
	8192843	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	1.23	CHEMBL5257	Homo sapiens	Inhibition	%	1.23
	8193067	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	3.87	CHEMBL5257	Homo sapiens	Inhibition	%	3.87
	8193115	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	18.01	CHEMBL5257	Homo sapiens	Inhibition	%	18.01
	8193339	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	7.94	CHEMBL5257	Homo sapiens	Inhibition	%	7.94
	8193484	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	5.67	CHEMBL5257	Homo sapiens	Inhibition	%	5.67
	8193641	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	5.97	CHEMBL5257	Homo sapiens	Inhibition	%	5.97
	8193865	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.34	CHEMBL5257	Homo sapiens	Inhibition	%	4.34
	8194014	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	2.28	CHEMBL5257	Homo sapiens	Inhibition	%	2.28
	8194369	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	6.41	CHEMBL5257	Homo sapiens	Inhibition	%	6.41
	8194500	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	3.53	CHEMBL5257	Homo sapiens	Inhibition	%	3.53
	8194724	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.67	CHEMBL5257	Homo sapiens	Inhibition	%	5.67
	8194867	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	3.74	CHEMBL5257	Homo sapiens	Inhibition	%	3.74
	8195224	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	8.58	CHEMBL5257	Homo sapiens	Inhibition	%	8.58
	8195388	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	6.51	CHEMBL5257	Homo sapiens	Inhibition	%	6.51
	8195751	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	5.12	CHEMBL5257	Homo sapiens	Inhibition	%	5.12
	8195849	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.7	CHEMBL5257	Homo sapiens	Inhibition	%	2.7
	8196073	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	-1.51	CHEMBL5257	Homo sapiens	Inhibition	%	-1.51
	8196190	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	7.36	CHEMBL5257	Homo sapiens	Inhibition	%	7.36
	8196564	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	-1.05	CHEMBL5257	Homo sapiens	Inhibition	%	-1.05
	8196692	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	6.3	CHEMBL5257	Homo sapiens	Inhibition	%	6.3
	8196916	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	5.68	CHEMBL5257	Homo sapiens	Inhibition	%	5.68
	8197057	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	3.57	CHEMBL5257	Homo sapiens	Inhibition	%	3.57
	8197418	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	7.2	CHEMBL5257	Homo sapiens	Inhibition	%	7.2
	8197693	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	19.14	CHEMBL5257	Homo sapiens	Inhibition	%	19.14
	8197833	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	9.22	CHEMBL5257	Homo sapiens	Inhibition	%	9.22
	8198214	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.21	CHEMBL5257	Homo sapiens	Inhibition	%	2.21
	8198352	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	1.67	CHEMBL5257	Homo sapiens	Inhibition	%	1.67
	8198706	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	11.57	CHEMBL5257	Homo sapiens	Inhibition	%	11.57
	8199061	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	6.39	CHEMBL5257	Homo sapiens	Inhibition	%	6.39
	8199209	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	14.31	CHEMBL5257	Homo sapiens	Inhibition	%	14.31
	8199567	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	10.82	CHEMBL5257	Homo sapiens	Inhibition	%	10.82
	8199730	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	5.76	CHEMBL5257	Homo sapiens	Inhibition	%	5.76
	8199954	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	8.55	CHEMBL5257	Homo sapiens	Inhibition	%	8.55
	8200092	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.88	CHEMBL5257	Homo sapiens	Inhibition	%	2.88
	8200420	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	5.9	CHEMBL5257	Homo sapiens	Inhibition	%	5.9
	8200535	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.93	CHEMBL5257	Homo sapiens	Inhibition	%	1.93
	8200759	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	0.45	CHEMBL5257	Homo sapiens	Inhibition	%	0.45
	8200909	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	5.94	CHEMBL5257	Homo sapiens	Inhibition	%	5.94
	8201263	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	28.44	CHEMBL5257	Homo sapiens	Inhibition	%	28.44
	8201398	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	9.27	CHEMBL5257	Homo sapiens	Inhibition	%	9.27
	8201755	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	3.4	CHEMBL5257	Homo sapiens	Inhibition	%	3.4
	8202034	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	7.55	CHEMBL5257	Homo sapiens	Inhibition	%	7.55
	8202174	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	55.47	CHEMBL5257	Homo sapiens	Inhibition	%	55.47
	8202398	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	2.02	CHEMBL5257	Homo sapiens	Inhibition	%	2.02
	8202565	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	6.52	CHEMBL5257	Homo sapiens	Inhibition	%	6.52
	8202690	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	7.41	CHEMBL5257	Homo sapiens	Inhibition	%	7.41
	8202914	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	12.63	CHEMBL5257	Homo sapiens	Inhibition	%	12.63
	8203044	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	10.7	CHEMBL5257	Homo sapiens	Inhibition	%	10.7
	8203399	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	9.14	CHEMBL5257	Homo sapiens	Inhibition	%	9.14
	8203545	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	10.62	CHEMBL5257	Homo sapiens	Inhibition	%	10.62
	8203769	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	14.81	CHEMBL5257	Homo sapiens	Inhibition	%	14.81
	8203903	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	8.71	CHEMBL5257	Homo sapiens	Inhibition	%	8.71
	8204293	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.6	CHEMBL5257	Homo sapiens	Inhibition	%	2.6
	8204430	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	2.78	CHEMBL5257	Homo sapiens	Inhibition	%	2.78
	8204759	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-3.71	CHEMBL5257	Homo sapiens	Inhibition	%	-3.71
	8205098	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	7.86	CHEMBL5257	Homo sapiens	Inhibition	%	7.86
	8205247	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	-1.68	CHEMBL5257	Homo sapiens	Inhibition	%	-1.68
	8205607	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	6.44	CHEMBL5257	Homo sapiens	Inhibition	%	6.44
	8205746	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	7.84	CHEMBL5257	Homo sapiens	Inhibition	%	7.84
	8205970	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	5.37	CHEMBL5257	Homo sapiens	Inhibition	%	5.37
	8206102	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-2.02	CHEMBL5257	Homo sapiens	Inhibition	%	-2.02
	8206378	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	10.08	CHEMBL5257	Homo sapiens	Inhibition	%	10.08
	8206745	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	8.59	CHEMBL5257	Homo sapiens	Inhibition	%	8.59
	8206925	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	8.39	CHEMBL5257	Homo sapiens	Inhibition	%	8.39
	8207275	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	6.55	CHEMBL5257	Homo sapiens	Inhibition	%	6.55
	8207405	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	16.34	CHEMBL5257	Homo sapiens	Inhibition	%	16.34
	8207629	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	13.9	CHEMBL5257	Homo sapiens	Inhibition	%	13.9
	8207761	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	6.19	CHEMBL5257	Homo sapiens	Inhibition	%	6.19
	8208130	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	9.51	CHEMBL5257	Homo sapiens	Inhibition	%	9.51
	8208262	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	7.56	CHEMBL5257	Homo sapiens	Inhibition	%	7.56
	8208652	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.14	CHEMBL5257	Homo sapiens	Inhibition	%	3.14
	8208785	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	-1.26	CHEMBL5257	Homo sapiens	Inhibition	%	-1.26
	8209009	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	8.67	CHEMBL5257	Homo sapiens	Inhibition	%	8.67
	8209114	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.87	CHEMBL5257	Homo sapiens	Inhibition	%	-0.87
	8209454	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	6.33	CHEMBL5257	Homo sapiens	Inhibition	%	6.33
	8209604	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	-2.57	CHEMBL5257	Homo sapiens	Inhibition	%	-2.57
	8209828	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	5.05	CHEMBL5257	Homo sapiens	Inhibition	%	5.05
	8209964	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	11.45	CHEMBL5257	Homo sapiens	Inhibition	%	11.45
	8210329	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	7.42	CHEMBL5257	Homo sapiens	Inhibition	%	7.42
	8210465	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.24	CHEMBL5257	Homo sapiens	Inhibition	%	0.24
	8210724	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	6.68	CHEMBL5257	Homo sapiens	Inhibition	%	6.68
	8211092	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	6.87	CHEMBL5257	Homo sapiens	Inhibition	%	6.87
	8211262	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	12.28	CHEMBL5257	Homo sapiens	Inhibition	%	12.28
	8211486	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.24	CHEMBL5257	Homo sapiens	Inhibition	%	4.24
	8211609	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	12.48	CHEMBL5257	Homo sapiens	Inhibition	%	12.48
	8211962	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	13.17	CHEMBL5257	Homo sapiens	Inhibition	%	13.17
	8212094	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.36	CHEMBL5257	Homo sapiens	Inhibition	%	2.36
	8212459	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	8.59	CHEMBL5257	Homo sapiens	Inhibition	%	8.59
	8212592	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	9.65	CHEMBL5257	Homo sapiens	Inhibition	%	9.65
	8212816	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.46	CHEMBL5257	Homo sapiens	Inhibition	%	4.46
	8212986	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.05	CHEMBL5257	Homo sapiens	Inhibition	%	2.05
	8213339	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.51	CHEMBL5257	Homo sapiens	Inhibition	%	1.51
	8213443	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.99	CHEMBL5257	Homo sapiens	Inhibition	%	-0.99
	8213667	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-5.68	CHEMBL5257	Homo sapiens	Inhibition	%	-5.68
	8213780	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	6.84	CHEMBL5257	Homo sapiens	Inhibition	%	6.84
	8214151	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.68	CHEMBL5257	Homo sapiens	Inhibition	%	3.68
	8214288	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	61.99	CHEMBL5257	Homo sapiens	Inhibition	%	61.99
	8214646	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	6.86	CHEMBL5257	Homo sapiens	Inhibition	%	6.86
	8214798	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.2	CHEMBL5257	Homo sapiens	Inhibition	%	0.2
	8215022	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1	Outside typical range	CHEMBL205158	=	Inhibition	%	-11.17	CHEMBL5257	Homo sapiens	Inhibition	%	-11.17
	8215049	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	11.61	CHEMBL5257	Homo sapiens	Inhibition	%	11.61
	8215273	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	9.19	CHEMBL5257	Homo sapiens	Inhibition	%	9.19
	8215426	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	7.0	CHEMBL5257	Homo sapiens	Inhibition	%	7.0
	8215814	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	12.33	CHEMBL5257	Homo sapiens	Inhibition	%	12.33
	8215933	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	2.99	CHEMBL5257	Homo sapiens	Inhibition	%	2.99
	8216276	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	8.05	CHEMBL5257	Homo sapiens	Inhibition	%	8.05
	8216412	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.52	CHEMBL5257	Homo sapiens	Inhibition	%	5.52
	8216636	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	8.42	CHEMBL5257	Homo sapiens	Inhibition	%	8.42
	8216774	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	6.43	CHEMBL5257	Homo sapiens	Inhibition	%	6.43
	8217132	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	7.69	CHEMBL5257	Homo sapiens	Inhibition	%	7.69
	8217306	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.25	CHEMBL5257	Homo sapiens	Inhibition	%	0.25
	8217661	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.17	CHEMBL5257	Homo sapiens	Inhibition	%	3.17
	8217986	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-2.24	CHEMBL5257	Homo sapiens	Inhibition	%	-2.24
	8218101	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.08	CHEMBL5257	Homo sapiens	Inhibition	%	4.08
	8218452	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	5.54	CHEMBL5257	Homo sapiens	Inhibition	%	5.54
	8218595	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	91.58	CHEMBL5257	Homo sapiens	Inhibition	%	91.58
	8218819	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	6.04	CHEMBL5257	Homo sapiens	Inhibition	%	6.04
	8218950	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	10.17	CHEMBL5257	Homo sapiens	Inhibition	%	10.17
	8219334	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1	Outside typical range	CHEMBL205158	=	Inhibition	%	-14.8	CHEMBL5257	Homo sapiens	Inhibition	%	-14.8
	8219584	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	15.25	CHEMBL5257	Homo sapiens	Inhibition	%	15.25
	8219745	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	6.76	CHEMBL5257	Homo sapiens	Inhibition	%	6.76
	8220138	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	9.06	CHEMBL5257	Homo sapiens	Inhibition	%	9.06
	8220267	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	15.27	CHEMBL5257	Homo sapiens	Inhibition	%	15.27
	8220491	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	7.5	CHEMBL5257	Homo sapiens	Inhibition	%	7.5
	8220605	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	28.85	CHEMBL5257	Homo sapiens	Inhibition	%	28.85
	8220967	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	8.07	CHEMBL5257	Homo sapiens	Inhibition	%	8.07
	8221103	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.36	CHEMBL5257	Homo sapiens	Inhibition	%	3.36
	8221327	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.66	CHEMBL5257	Homo sapiens	Inhibition	%	3.66
	8221460	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	9.89	CHEMBL5257	Homo sapiens	Inhibition	%	9.89
	8221625	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	2.53	CHEMBL5257	Homo sapiens	Inhibition	%	2.53
	8221849	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.84	CHEMBL5257	Homo sapiens	Inhibition	%	-1.84
	8221980	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	1.96	CHEMBL5257	Homo sapiens	Inhibition	%	1.96
	8222302	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	5.45	CHEMBL5257	Homo sapiens	Inhibition	%	5.45
	8222436	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.4	CHEMBL5257	Homo sapiens	Inhibition	%	4.4
	8222660	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	3.91	CHEMBL5257	Homo sapiens	Inhibition	%	3.91
	8222778	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	1.36	CHEMBL5257	Homo sapiens	Inhibition	%	1.36
	8223146	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	39.32	CHEMBL5257	Homo sapiens	Inhibition	%	39.32
	8223275	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	9.72	CHEMBL5257	Homo sapiens	Inhibition	%	9.72
	8223499	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	10.32	CHEMBL5257	Homo sapiens	Inhibition	%	10.32
	8223660	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.22	CHEMBL5257	Homo sapiens	Inhibition	%	0.22
	8223910	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	6.52	CHEMBL5257	Homo sapiens	Inhibition	%	6.52
	8224072	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	6.24	CHEMBL5257	Homo sapiens	Inhibition	%	6.24
	8224296	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.79	CHEMBL5257	Homo sapiens	Inhibition	%	5.79
	8224466	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	13.56	CHEMBL5257	Homo sapiens	Inhibition	%	13.56
	8224825	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	10.07	CHEMBL5257	Homo sapiens	Inhibition	%	10.07
	8224939	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	5.83	CHEMBL5257	Homo sapiens	Inhibition	%	5.83
	8225163	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	8.4	CHEMBL5257	Homo sapiens	Inhibition	%	8.4
	8225297	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	4.44	CHEMBL5257	Homo sapiens	Inhibition	%	4.44
	8225659	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	4.73	CHEMBL5257	Homo sapiens	Inhibition	%	4.73
	8225794	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.56	CHEMBL5257	Homo sapiens	Inhibition	%	4.56
	8226176	CHEMBL1962095	GSK_PKIS: NEK9 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.29	CHEMBL5257	Homo sapiens	Inhibition	%	-1.29
	8226301	CHEMBL1962094	GSK_PKIS: NEK9 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	8.89	CHEMBL5257	Homo sapiens	Inhibition	%	8.89
	10839425	CHEMBL2015410	Inhibition of NEK9 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	0.0	CHEMBL5257	Homo sapiens	INH	%	0.0
	12047284	CHEMBL2157309	Inhibition of NEK9 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	0.8	CHEMBL5257	Homo sapiens	INH	%	0.8
	12172312	CHEMBL2215427	Inhibition of NEK9 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL5257	Homo sapiens	Activity	%	100.0
	12183841	CHEMBL2211974	Inhibition of NEK9	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL5257	Homo sapiens	pIC50		5.0
	12727708	CHEMBL2350886	Inhibition of NEK9 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	89.0	CHEMBL5257	Homo sapiens	Activity	%	89.0
	12728996	CHEMBL2350173	Inhibition of NEK9 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	97.0	CHEMBL5257	Homo sapiens	Activity	%	97.0
	12729882	CHEMBL2349786	Inhibition of NEK9 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	78.0	CHEMBL5257	Homo sapiens	Activity	%	78.0
	12730139	CHEMBL2350886	Inhibition of NEK9 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	88.0	CHEMBL5257	Homo sapiens	Activity	%	88.0
	13374421	CHEMBL2406675	Inhibition of NEK9 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	2.0	CHEMBL5257	Homo sapiens	INH	%	2.0
	13434642	CHEMBL2424427	Inhibition of NEK9 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	13434643	CHEMBL2424427	Inhibition of NEK9 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	13434644	CHEMBL2424427	Inhibition of NEK9 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	13434645	CHEMBL2424427	Inhibition of NEK9 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	13434646	CHEMBL2424427	Inhibition of NEK9 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	13434647	CHEMBL2424427	Inhibition of NEK9 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	13434648	CHEMBL2424427	Inhibition of NEK9 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	13434649	CHEMBL2424427	Inhibition of NEK9 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	13434650	CHEMBL2424427	Inhibition of NEK9 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	13434651	CHEMBL2424427	Inhibition of NEK9 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	13434652	CHEMBL2424427	Inhibition of NEK9 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	13434653	CHEMBL2424427	Inhibition of NEK9 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL5257	Homo sapiens	INH	%	35.0
	13442329	CHEMBL2429498	Competitive binding affinity to NEK9 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	13445464	CHEMBL2429498	Competitive binding affinity to NEK9 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	13448519	CHEMBL2429498	Competitive binding affinity to NEK9 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	13448655	CHEMBL2429498	Competitive binding affinity to NEK9 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	13451450	CHEMBL2429498	Competitive binding affinity to NEK9 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	13454635	CHEMBL2429498	Competitive binding affinity to NEK9 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	81.0	CHEMBL5257	Homo sapiens	INH	%	81.0
	15018653	CHEMBL3361545	Inhibition of NEK9 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	7.2	CHEMBL5257	Homo sapiens	INH	%	7.2
	15756885	CHEMBL3630743	Inhibition of NEK9 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	20.85	CHEMBL5257	Homo sapiens	INH	%	20.85
	15757838	CHEMBL3630743	Inhibition of NEK9 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	100.01	CHEMBL5257	Homo sapiens	INH	%	100.01
	15758817	CHEMBL3630743	Inhibition of NEK9 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	-6.23	CHEMBL5257	Homo sapiens	INH	%	-6.23
	16426122	CHEMBL3750449	Inhibition of NEK9 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-7.6	CHEMBL5257	Homo sapiens	INH	%	-7.6
	16431933	CHEMBL3748026	Inhibition of human NEK9 using MBP as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	5000.0	CHEMBL5257	Homo sapiens	IC50	uM	5.0
	16451542	CHEMBL3760665	Inhibition of NEK9 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-0.2	CHEMBL5257	Homo sapiens	INH	%	-0.2
	16472976	CHEMBL3768611	Inhibition of human NEK9	B	COCCOc1cc2c(-n3nc(-c4ccccn4)nc3N)ncnc2cc1OC		CHEMBL3763358	>	Inhibition	%	95.0	CHEMBL5257	Homo sapiens	INH	%	95.0
	16614564	CHEMBL3817595	Inhibition of human NEK9 at 1 uM using MBP as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	3.0	CHEMBL5257	Homo sapiens	INH	%	3.0
	16618143	CHEMBL3817342	Inhibition of recombinant human GST-tagged NEK9 catalytic domain (347 to 732 residues) expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
Inactive	17921710	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921711	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921712	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921713	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921714	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921715	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921716	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921717	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921718	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921719	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921720	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921721	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921722	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921723	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921724	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921725	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921726	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921727	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921728	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921729	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921730	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921731	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921732	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921733	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921734	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921735	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921736	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921737	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921738	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921739	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921740	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921741	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921742	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921743	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921744	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921745	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921746	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921747	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921748	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921749	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921750	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921751	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921752	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921753	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921754	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921755	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921756	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921757	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Active	17921758	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	=	Kd	nM	41.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	41.0
Inactive	17921759	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921760	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921761	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921762	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921763	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921764	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921765	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921766	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921767	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921768	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921769	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921770	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921771	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921772	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921773	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921774	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921775	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921776	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921777	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921778	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921779	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921780	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921781	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921782	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921783	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921784	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921785	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921786	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921787	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921788	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921789	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921790	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921791	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921792	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921793	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Active	17921794	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	133.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	133.0
Inactive	17921795	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921796	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921797	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921798	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921799	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921800	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921801	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921802	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921803	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921804	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Active	17921805	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1492.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	1492.0
Inactive	17921806	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921807	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921808	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Active	17921809	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	1634.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	1634.0
Inactive	17921810	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921811	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921812	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921813	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921814	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921815	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921816	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921817	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921818	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921819	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921820	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921821	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921822	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921823	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921824	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921825	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921826	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921827	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921828	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921829	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921830	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921831	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Active	17921832	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	=	Kd	nM	654.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	654.0
Inactive	17921833	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921834	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921835	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921836	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921837	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921838	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921839	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921840	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921841	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921842	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921843	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921844	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921845	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921846	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Active	17921847	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	53.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	53.0
Inactive	17921848	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921849	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921850	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921851	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921852	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921853	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921854	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921855	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921856	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921857	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921858	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921859	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921860	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921861	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921862	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Active	17921863	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	=	Kd	nM	474.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	474.0
Inactive	17921864	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921865	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921866	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921867	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921868	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921869	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921870	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921871	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921872	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921873	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Active	17921874	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	=	Kd	nM	2186.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	2186.0
Inactive	17921875	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Active	17921876	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	Kd	nM	2977.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	2977.0
Active	17921877	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	1532.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	1532.0
Inactive	17921878	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921879	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921880	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921881	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921882	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921883	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921884	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921885	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921886	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921887	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921888	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921889	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Active	17921890	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	2051.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	2051.0
Inactive	17921891	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921892	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921893	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921894	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921895	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921896	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921897	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921898	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921899	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921900	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921901	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921902	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921903	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921904	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921905	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921906	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921907	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921908	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921909	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921910	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921911	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921912	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Active	17921913	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	180.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	180.0
Inactive	17921914	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921915	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921916	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921917	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921918	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921919	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921920	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921921	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921922	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921923	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921924	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921925	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921926	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921927	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921928	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921929	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921930	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Active	17921931	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	=	Kd	nM	1780.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	1780.0
Inactive	17921932	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Active	17921933	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	19617.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	19617.0
Inactive	17921934	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921935	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921936	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921937	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921938	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921939	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921940	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921941	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921942	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921943	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921944	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921945	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921946	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Active	17921947	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	2034.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	2034.0
Inactive	17921948	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921949	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921950	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921951	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921952	CHEMBL3991802	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5257	Homo sapiens	Kd apparent	nM	30000.0
	18114217	CHEMBL4025277	Inhibition of wild-type human partial length NEK9 (P32 to R328 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	98.0	CHEMBL5257	Homo sapiens	Activity	%	98.0
	18153055	CHEMBL4034430	Inhibition of NEK9 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	13.1	CHEMBL5257	Homo sapiens	INH	%	13.1
	18153259	CHEMBL4034429	Inhibition of NEK9 Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	14.7	CHEMBL5257	Homo sapiens	INH	%	14.7
	18203801	CHEMBL4044088	Inhibition of wild-type human partial length NEK9 (P32 to R328 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL5257	Homo sapiens	Activity	%	100.0
	18211526	CHEMBL4045781	Inhibition of NEK9 conserved Lys2 (DIKTLNIFLTK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	25.5	CHEMBL5257	Homo sapiens	INH	%	25.5
	18211527	CHEMBL4045780	Inhibition of NEK9 conserved Lys1 (RTEDDSLVVWKEVDLTR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	10.4	CHEMBL5257	Homo sapiens	INH	%	10.4
	18211925	CHEMBL4046021	Inhibition of NEK9 conserved Lys1 (RTEDDSLVVWKEVDLTR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	10.3	CHEMBL5257	Homo sapiens	INH	%	10.3
	18211926	CHEMBL4046022	Inhibition of NEK9 conserved Lys2 (DIKTLNIFLTK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	26.5	CHEMBL5257	Homo sapiens	INH	%	26.5
	18253887	CHEMBL4055228	Inhibition of wild-type human partial length NEK9 (P32 to R328 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL5257	Homo sapiens	Activity	%	100.0
	18253888	CHEMBL4055228	Inhibition of wild-type human partial length NEK9 (P32 to R328 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL5257	Homo sapiens	Activity	%	100.0
	18265812	CHEMBL4057262	Inhibition of NEK9 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	1.7	CHEMBL5257	Homo sapiens	INH	%	1.7
	18266010	CHEMBL4057460	Inhibition of NEK9 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	1.7	CHEMBL5257	Homo sapiens	INH	%	1.7
	18275154	CHEMBL4118430	Inhibition of NEK9 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKTLNIFLTK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	3.2	CHEMBL5257	Homo sapiens	INH	%	3.2
	18275155	CHEMBL4118430	Inhibition of NEK9 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKTLNIFLTK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	9.0	CHEMBL5257	Homo sapiens	INH	%	9.0
	18275156	CHEMBL4118430	Inhibition of NEK9 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKTLNIFLTK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	24.7	CHEMBL5257	Homo sapiens	INH	%	24.7
Active	18275728	CHEMBL4118688	Binding affinity to NEK9 in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL5257	Homo sapiens	Activity		
Active	18275906	CHEMBL4118866	Binding affinity to NEK9 in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL5257	Homo sapiens	Activity		
	18282135	CHEMBL4120090	Inhibition of recombinant full length GST-tagged human NEK9 catalytic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	-3.4	CHEMBL5257	Homo sapiens	INH	%	-3.4
	18282454	CHEMBL4120090	Inhibition of recombinant full length GST-tagged human NEK9 catalytic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F	Outside typical range	CHEMBL3715238	=	Inhibition	%	-15.6	CHEMBL5257	Homo sapiens	INH	%	-15.6
	18282859	CHEMBL4120444	Inhibition of NEK9 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	1.7	CHEMBL5257	Homo sapiens	INH	%	1.7
	18283073	CHEMBL4120658	Inhibition of NEK9 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-3.0	CHEMBL5257	Homo sapiens	INH	%	-3.0
	18283254	CHEMBL4120839	Inhibition of NEK9 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	0.3	CHEMBL5257	Homo sapiens	INH	%	0.3
	18440343	CHEMBL4157167	Binding affinity to wild-type human partial length NEK9 (P32 to R328 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	84.0	CHEMBL5257	Homo sapiens	Activity	%	84.0
	18484299	CHEMBL4185946	Binding affinity to wild-type human partial length NEK9 (P32 to R328 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	97.0	CHEMBL5257	Homo sapiens	Activity	%	97.0
	18484783	CHEMBL4185946	Binding affinity to wild-type human partial length NEK9 (P32 to R328 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL5257	Homo sapiens	Activity	%	100.0
	18507966	CHEMBL4191086	Inhibition of recombinant human NEK9 (1 to 324 residues) at 1 uM using myelin basic protein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	11.0	CHEMBL5257	Homo sapiens	INH	%	11.0
	18653483	CHEMBL4230162	Inhibition of NEK9 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	2.0	CHEMBL5257	Homo sapiens	INH	%	2.0
	18653484	CHEMBL4230162	Inhibition of NEK9 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	-1.0	CHEMBL5257	Homo sapiens	INH	%	-1.0
	18655389	CHEMBL4230846	Binding affinity to wild-type human partial length NEK9 (P32 to R328 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	92.0	CHEMBL5257	Homo sapiens	Activity	%	92.0
	18751172	CHEMBL4263881	Inhibition of NEK9 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	9.0	CHEMBL5257	Homo sapiens	INH	%	9.0
	18752098	CHEMBL4264435	Binding affinity to wild-type human partial length NEK9 (P32 to R328 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	89.0	CHEMBL5257	Homo sapiens	Activity	%	89.0
	18858099	CHEMBL4307945	Binding affinity to wild-type human partial length NEK9 (P32 to R328 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL5257	Homo sapiens	Activity	%	100.0
	18892674	CHEMBL4314575	Inhibition of recombinant human NEK9 (1 to 324 residues) assessed as residual activity at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	102.0	CHEMBL5257	Homo sapiens	Activity	%	102.0
	18938153	CHEMBL4327803	Inhibition of human NEK9 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	93.83	CHEMBL5257	Homo sapiens	Activity	%	93.83
	18938154	CHEMBL4327803	Inhibition of human NEK9 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	93.4	CHEMBL5257	Homo sapiens	Activity	%	93.4
	18938648	CHEMBL4328167	Inhibition of human NEK9 assessed as residual activity at 100 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5257	Homo sapiens	Activity	%	65.0
	18939030	CHEMBL4328531	Inhibition of human NEK9 using casein as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	131.0	CHEMBL5257	Homo sapiens	IC50	10'-7M	1.31
	18958660	CHEMBL4333531	Binding affinity to wild-type human partial length NEK9 (P32 to R328 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	85.0	CHEMBL5257	Homo sapiens	Activity	%	85.0
	18964527	CHEMBL4335204	Inhibition of recombinant human NEK9 (1 to 324 residues) assessed as residual activity at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	103.0	CHEMBL5257	Homo sapiens	Activity	%	103.0
	18964528	CHEMBL4335204	Inhibition of recombinant human NEK9 (1 to 324 residues) assessed as residual activity at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	101.0	CHEMBL5257	Homo sapiens	Activity	%	101.0
	18972018	CHEMBL4337028	Inhibition of recombinant human NEK9 (1 to 324 residues) assessed as residual activity at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	97.0	CHEMBL5257	Homo sapiens	Activity	%	97.0
Not Active	19040076	CHEMBL4351980	Inhibition of recombinant human NEK9 (1 to 324 residues) at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5257	Homo sapiens	INH		
Active	19041210	CHEMBL4352471	Inhibition of human NEK9 at 10 uM using casein as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5257	Homo sapiens	INH		
	19059723	CHEMBL4358024	Binding affinity to wild-type human partial length NEK9 (P32 to R328 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL5257	Homo sapiens	Activity	%	100.0
	19090288	CHEMBL4365862	Inhibition of wild-type human partial length NEK9 (P32 to R328 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL5257	Homo sapiens	Activity	%	100.0
	19092041	CHEMBL4366515	Inhibition of human NEK9 at 100 nM using casein as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	10.43	CHEMBL5257	Homo sapiens	INH	%	10.43
	19144722	CHEMBL4377738	Inhibition of recombinant human NEK9 (1 to 324 residues) at 1 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	41.0	CHEMBL5257	Homo sapiens	INH	%	41.0
	19147964	CHEMBL4379250	Inhibition of recombinant human NEK9 (1 to 324 residues) using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL5257	Homo sapiens	IC50	uM	10.0
	19159551	CHEMBL4382655	Binding affinity to wild-type human partial length NEK9 (P32 to R328 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	70.0	CHEMBL5257	Homo sapiens	Activity	%	70.0
	19181101	CHEMBL4387312	Inhibition of recombinant human GST-tagged NEK9 catalytic domain (347 to 732 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	2.0	CHEMBL5257	Homo sapiens	INH	%	2.0
	19181326	CHEMBL4387312	Inhibition of recombinant human GST-tagged NEK9 catalytic domain (347 to 732 residues) expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	-1.5	CHEMBL5257	Homo sapiens	INH	%	-1.5
	19191456	CHEMBL4389374	Inhibition of wild-type human partial length NEK9 (P32 to R328 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	95.0	CHEMBL5257	Homo sapiens	INH	%	95.0
	19192037	CHEMBL4389851	Inhibition of wild-type human partial length NEK9 (P32 to R328 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	95.0	CHEMBL5257	Homo sapiens	INH	%	95.0
	19200293	CHEMBL4391477	Binding affinity to wild-type human partial length NEK9 (P32 to R328 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	62.0	CHEMBL5257	Homo sapiens	Activity	%	62.0
	19266538	CHEMBL4405488	Inhibition of wild-type human partial length NEK9 (P32 to R328 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	19276064	CHEMBL4408067	Inhibition of recombinant human NEK9 (1 to 324 residues) at 1 uM using myelin basic protein as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	71.0	CHEMBL5257	Homo sapiens	INH	%	71.0
	20600606	CHEMBL4603558	Inhibition of recombinant human GST-tagged NEK9 catalytic domain (347 to 732 residues) expressed in baculovirus expression system using serine/threonine-7 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL5257	Homo sapiens	IC50	uM	100.0
	22392121	CHEMBL4667216	Inhibition of recombinant human GST-tagged NEK9 (347 to 732 residues) expressed in baculovirus expression system using Ser/Thr 07 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	3.0	CHEMBL5257	Homo sapiens	INH	%	3.0
	22423080	CHEMBL4674095	Inhibition of human NEK9 using casein as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL5257	Homo sapiens	INH	%	80.0
	22423391	CHEMBL4674271	Inhibition of human NEK9 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	94.11	CHEMBL5257	Homo sapiens	Activity	%	94.11
	22423392	CHEMBL4674271	Inhibition of human NEK9 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	99.05	CHEMBL5257	Homo sapiens	Activity	%	99.05
	22843638	CHEMBL4720624	Inhibition of human NEK9 using casein as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	71.0	CHEMBL5257	Homo sapiens	IC50	10^-8M	7.1
	22843985	CHEMBL4720971	Inhibition of human NEK9 assessed as residual activity using casein as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	50.88	CHEMBL5257	Homo sapiens	Activity	%	50.88
	22844799	CHEMBL4721474	Inhibition of wild-type human partial length NEK9 (P32 to R328 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	100.09	CHEMBL5257	Homo sapiens	Activity	%	100.09
	22952929	CHEMBL4766866	Inhibition of recombinant human NEK9 (1 to 324 residues) assessed as residual activity at 10 uM using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	7.0	CHEMBL5257	Homo sapiens	Activity	%	7.0
	22953097	CHEMBL4767034	Inhibition of recombinant human NEK9 (1 to 324 residues) using myelin basic protein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	1803.0	CHEMBL5257	Homo sapiens	IC50	uM	1.8030000000000002
	23120794	CHEMBL4804449	Inhibition of NEK9 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855542	=	IC50	nM	-10000.0	CHEMBL5257	Homo sapiens	IC50	uM	-10.0
	23120795	CHEMBL4804449	Inhibition of NEK9 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-4700.0	CHEMBL5257	Homo sapiens	IC50	uM	-4.7
	23120796	CHEMBL4804449	Inhibition of NEK9 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	61500.0	CHEMBL5257	Homo sapiens	IC50	uM	61.5
	23120797	CHEMBL4804449	Inhibition of NEK9 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-20800.0	CHEMBL5257	Homo sapiens	IC50	uM	-20.8
	23120798	CHEMBL4804449	Inhibition of NEK9 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-27800.0	CHEMBL5257	Homo sapiens	IC50	uM	-27.8
	23120799	CHEMBL4804449	Inhibition of NEK9 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4859660	=	IC50	nM	-38300.0	CHEMBL5257	Homo sapiens	IC50	uM	-38.3
	23121832	CHEMBL4804631	Inhibition of NEK9 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL5257	Homo sapiens	INH	%	0.0
	23121833	CHEMBL4804631	Inhibition of NEK9 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL5257	Homo sapiens	INH	%	0.0
	23121834	CHEMBL4804631	Inhibition of NEK9 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	50.0	CHEMBL5257	Homo sapiens	INH	%	50.0
	23121835	CHEMBL4804631	Inhibition of NEK9 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL5257	Homo sapiens	INH	%	0.0
	23121836	CHEMBL4804631	Inhibition of NEK9 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL5257	Homo sapiens	INH	%	0.0
	23121837	CHEMBL4804631	Inhibition of NEK9 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL5257	Homo sapiens	INH	%	0.0
	23122708	CHEMBL4805059	Inhibition of human NEK9 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	97.0	CHEMBL5257	Homo sapiens	Activity	%	97.0
	23123403	CHEMBL4805647	Inhibition of human NEK9 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	83.0	CHEMBL5257	Homo sapiens	Activity	%	83.0
	23123861	CHEMBL4806105	Inhibition of DNA-tagged human NEK9 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	33.0	CHEMBL5257	Homo sapiens	Activity	%	33.0
	23124896	CHEMBL4806664	Inhibition of human NEK9 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5257	Homo sapiens	Activity	%	100.0
	23124897	CHEMBL4806664	Inhibition of human NEK9 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	89.0	CHEMBL5257	Homo sapiens	Activity	%	89.0
	23128380	CHEMBL4807935	Inhibition of NEK9 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL5257	Homo sapiens	Activity	%	75.0
	23128381	CHEMBL4807935	Inhibition of NEK9 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL5257	Homo sapiens	Activity	%	75.0
	23128382	CHEMBL4807935	Inhibition of NEK9 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL5257	Homo sapiens	Activity	%	75.0
Not Active	23317544	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	79.0	CHEMBL5257	Homo sapiens	% Control	%	79.0
Not Active	23318012	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23318678	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	72.0	CHEMBL5257	Homo sapiens	% Control	%	72.0
Not Active	23319162	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23319799	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23320274	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	84.2	CHEMBL5257	Homo sapiens	% Control	%	84.2
Not Active	23320952	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23321420	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23322050	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	95.0	CHEMBL5257	Homo sapiens	% Control	%	95.0
Not Active	23322518	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23323207	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23323675	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23324529	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	95.6	CHEMBL5257	Homo sapiens	% Control	%	95.6
Not Active	23325164	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	91.0	CHEMBL5257	Homo sapiens	% Control	%	91.0
Not Active	23325632	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23326279	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	83.0	CHEMBL5257	Homo sapiens	% Control	%	83.0
Not Active	23326747	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	94.0	CHEMBL5257	Homo sapiens	% Control	%	94.0
Not Active	23327447	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23327915	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	72.0	CHEMBL5257	Homo sapiens	% Control	%	72.0
Not Active	23328502	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	95.0	CHEMBL5257	Homo sapiens	% Control	%	95.0
Not Active	23328970	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23329450	CHEMBL4881157	NEK9(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	92.0	CHEMBL5257	Homo sapiens	% residual kinase activity	%	92.0
Not Active	23329916	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23330384	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	94.0	CHEMBL5257	Homo sapiens	% Control	%	94.0
Not Active	23331140	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23331608	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23332195	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	72.2	CHEMBL5257	Homo sapiens	% Control	%	72.2
Not Active	23332661	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23333379	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23334018	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23334486	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23335465	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	96.0	CHEMBL5257	Homo sapiens	% Control	%	96.0
Not Active	23335933	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23336560	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	77.0	CHEMBL5257	Homo sapiens	% Control	%	77.0
Not Active	23337028	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23337697	CHEMBL4882068	NEK9 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	106.0	CHEMBL5257	Homo sapiens	% Ctrl	%	106.0
Not Active	23338109	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	95.0	CHEMBL5257	Homo sapiens	% Control	%	95.0
Not Active	23338577	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23339189	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	99.0	CHEMBL5257	Homo sapiens	% Control	%	99.0
Not Active	23339657	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	83.0	CHEMBL5257	Homo sapiens	% Control	%	83.0
Not Active	23340294	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23340762	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23341419	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23341887	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23342503	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	99.0	CHEMBL5257	Homo sapiens	% Control	%	99.0
Not Active	23342971	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23343601	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	98.0	CHEMBL5257	Homo sapiens	% Control	%	98.0
Not Active	23344069	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	99.0	CHEMBL5257	Homo sapiens	% Control	%	99.0
Not Active	23344707	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23345280	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23345748	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23346325	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	92.8	CHEMBL5257	Homo sapiens	% Control	%	92.8
Not Active	23346793	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	80.3	CHEMBL5257	Homo sapiens	% Control	%	80.3
Not Active	23347395	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	77.5	CHEMBL5257	Homo sapiens	% Control	%	77.5
Not Active	23347885	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23348464	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23348932	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23349519	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23350137	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23350605	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23351210	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23351678	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	81.0	CHEMBL5257	Homo sapiens	% Control	%	81.0
Not Active	23352150	CHEMBL4882839	NEK9 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	-0.9989	CHEMBL5257	Homo sapiens	% Inhibition	%	-0.9989
Not Active	23352702	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23353170	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	71.0	CHEMBL5257	Homo sapiens	% Control	%	71.0
Not Active	23354052	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23354520	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23355252	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23355720	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23356356	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23356824	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23357433	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23358080	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23358548	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23359134	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	98.2	CHEMBL5257	Homo sapiens	% Control	%	98.2
Not Active	23359732	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	79.0	CHEMBL5257	Homo sapiens	% Control	%	79.0
Not Active	23360200	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	97.0	CHEMBL5257	Homo sapiens	% Control	%	97.0
Not Active	23360785	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23361253	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	98.0	CHEMBL5257	Homo sapiens	% Control	%	98.0
Not Active	23361826	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	96.0	CHEMBL5257	Homo sapiens	% Control	%	96.0
Not Active	23362362	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23362830	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23364472	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	95.0	CHEMBL5257	Homo sapiens	% Control	%	95.0
Not Active	23364940	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23365679	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	95.0	CHEMBL5257	Homo sapiens	% Control	%	95.0
Not Active	23366222	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	97.0	CHEMBL5257	Homo sapiens	% Control	%	97.0
Not Active	23366812	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23367280	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23367674	CHEMBL4884027	NEK9 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	104.0	CHEMBL5257	Homo sapiens	% Residual activity with Skepinone-L	%	104.0
Not Active	23368158	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	90.0	CHEMBL5257	Homo sapiens	% Control	%	90.0
Not Active	23368626	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	88.0	CHEMBL5257	Homo sapiens	% Control	%	88.0
Not Active	23369225	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23369693	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23370168	CHEMBL4884410	NEK9(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	47.0	CHEMBL5257	Homo sapiens	% residual kinase activity	%	47.0
Not Active	23370661	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	93.0	CHEMBL5257	Homo sapiens	% Control	%	93.0
Not Active	23371129	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23371938	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23372406	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
	23372830	CHEMBL4884795	Nek9(NEK9LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL5257	Homo sapiens	pIC50		6.0
	23373239	CHEMBL4885086	Nek9(NEK9LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL5257	Homo sapiens	pIC50		6.0
	23373596	CHEMBL4885373	Nek9(NEK9LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5257	Homo sapiens	pIC50		6.0
Not Active	23375056	CHEMBL4886044	NEK9 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	-2.5	CHEMBL5257	Homo sapiens	% Inhibition	%	-2.5
Not Active	23375833	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	80.0	CHEMBL5257	Homo sapiens	% Control	%	80.0
Not Active	23376301	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	96.0	CHEMBL5257	Homo sapiens	% Control	%	96.0
Not Active	23376878	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	96.0	CHEMBL5257	Homo sapiens	% Control	%	96.0
Not Active	23377346	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	75.0	CHEMBL5257	Homo sapiens	% Control	%	75.0
Not Active	23378206	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	78.0	CHEMBL5257	Homo sapiens	% Control	%	78.0
Not Active	23378674	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	95.0	CHEMBL5257	Homo sapiens	% Control	%	95.0
Not Active	23379841	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23380309	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	99.0	CHEMBL5257	Homo sapiens	% Control	%	99.0
Not Active	23381003	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23381651	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL5257	Homo sapiens	% Control	%	100.0
Not Active	23382119	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	86.0	CHEMBL5257	Homo sapiens	% Control	%	86.0
Not Active	23382743	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	80.0	CHEMBL5257	Homo sapiens	% Control	%	80.0
Not Active	23383211	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	63.0	CHEMBL5257	Homo sapiens	% Control	%	63.0
Not Active	23383903	CHEMBL4887519	NEK9 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	99.0	CHEMBL5257	Homo sapiens	% Ctrl	%	99.0
Not Active	23384382	CHEMBL4887977	NEK9(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	6.61	CHEMBL5257	Homo sapiens	% inhibition	%	6.61
Not Active	23385126	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	77.0	CHEMBL5257	Homo sapiens	% Control	%	77.0
Not Active	23385593	CHEMBL4879850	KinomeScan assay: inhibition of NEK9	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	90.0	CHEMBL5257	Homo sapiens	% Control	%	90.0
